propranolol has been researched along with Cardiac Failure in 322 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "HRV was analysed in 14 infants with severe heart failure due to CHD who received a 'standard' therapy with digoxin and diuretics ('Digoxin/Diuretics' group) and in 9 of these patients with an additional propranolol therapy ('Propranolol' group) 17 days later on average and compared with HRV of 70 healthy infants ('Healthy Control')." | 9.10 | Heart rate variability in infants with heart failure due to congenital heart disease: reversal of depressed heart rate variability by propranolol. ( Buchhorn, R; Hulpke-Wette, M; Nothroff, J; Paul, T, 2002) |
| "This study evaluated the effects of propranolol on recovery of heart rate variability (HRV) after acute myocardial infarction and its relation to outcome in the Beta-blocker Heart Attack Trial (BHAT)." | 9.10 | Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial. ( Horwitz, RI; Ickovics, JR; Lampert, R; Lee, FA; Viscoli, CJ, 2003) |
| " After 17 days on average beta-blocker treated infants (propranolol:1,6 mg/kg/day) improved significantly with respect to Ross heart failure score (3." | 9.09 | Propranolol treatment of congestive heart failure in infants with congenital heart disease: The CHF-PRO-INFANT Trial. Congestive heart failure in infants treated with propanol. ( Bartmus, D; Buchhorn, R; Bürsch, J; Hilgers, R; Hulpke-Wette, M; Wessel, A, 2001) |
| "At 32-month follow-up of older patients with prior myocardial infarction, congestive heart failure, and a left ventricular ejection fraction > or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitors, and also with digoxin if atrial fibrillation was present, propranolol caused a 35% significant reduction in total mortality and a 37% significant decrease in total mortality plus nonfatal myocardial infarction compared with no propranolol." | 9.08 | Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus ( Ahn, C; Aronow, WS; Kronzon, I, 1997) |
| "The incidence of congestive heart failure was studied in the Beta Blocker Heart Attack Trial in which postmyocardial infarction patients between the ages of 30 and 69 years, with no contraindication to propranolol, were randomly assigned to receive placebo (n = 1921) or propranolol 180 or 240 mg daily (n = 1916) 5 to 21 days after admission to the hospital for the event." | 9.06 | Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. ( Byington, R; Chadda, K; Curb, JD; Goldstein, S, 1986) |
| "The beta-Blocker Heart Attack Trial (BHAT) was a placebo-controlled, randomized, double-blind clinical trial of the long-term administration of propranolol hydrochloride to persons who had had at least one confirmed myocardial infarction." | 9.05 | A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results. ( , 1983) |
| "Multiclinic controlled studies have shown that enalapril alone 10 to 40 mg/day orally is effective in lowering blood pressure in patients with essential hypertension." | 8.77 | Enalapril in hypertension and congestive heart failure. Overall review of efficacy and safety. ( Davies, RO; Moncloa, F; Sromovsky, JA; Walker, JF, 1985) |
| "To assess the efficacy of transcatheter arterial embolization (TAE) plus propranolol treatment for infantile hepatic hemangioma (IHH)." | 8.12 | Clinical evaluation of transcatheter arterial embolization combined with propranolol orally treatment of infantile hepatic hemangioma. ( Guo, L; Li, J; Song, D; Wang, L, 2022) |
| "Transcatheter arterial embolization combined with propranolol is an effective treatment for life-threatening infantile hepatic hemangioendothelioma." | 7.96 | Infantile hepatic hemangioendothelioma associated with pulmonary artery hypertension and cardiac insufficiency successfully treated with transcatheter arterial embolization and propranolol: A case report. ( Guo, L; Li, J; Song, D; Wang, L; Wu, C; Yin, J, 2020) |
| "We report the rapid and dramatic efficacy of propranolol in 8 infants with infantile hepatic hemangiomas." | 7.76 | Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. ( Ammour, A; Benlahrech, S; Bodemer, C; Broue, P; Hoeger, PH; Labenne, M; Léauté-Labrèze, C; Mazereeuw-Hautier, J; Ohanessian, G; Rössler, J; Vabres, P; Vial, J, 2010) |
| "Large clinical trials using the betablockers carvedilol, metoprolol, bisoprolol and nebivolol have demonstrated improvement of survival and symptoms in patients with heart failure." | 7.76 | Replacement of carvedilol for propranolol in patients with heart failure. ( Castro, RB; Gallo, L; Maciel, BC; Marques, F; Nobre, F; Pintya, AO; Simões, MV, 2010) |
| "Heart failure (HF) may be produced by sustained beta-adrenoceptor stimulation by causing changes in the expression of endothelin-1 (ET-1), the leptin system, calcineurin and sarcoplasmic reticulum Ca2+ ATPase 2a (SERCA2a) underlying cardiac dysfunction." | 7.74 | Protective effect of the endothelin antagonist CPU0213 against isoprenaline-induced heart failure by suppressing abnormal expression of leptin, calcineurin and SERCA2a in rats. ( Dai, DZ; Dai, Y; Ji, H; Tang, XY; Xu, M, 2008) |
| "Fifteen patients with heart failure and using propranolol were assessed over a period of 12 months." | 7.70 | Effects of propranolol on the QT dispersion in congestive heart failure. ( Cramer, H; de Deus, FC; dos Santos, PA; dos Santos, VB; Guedes, CR; Maia, ER; Mesquita, ET; Romeo, LJ; Subieta, CG; Villacorta, H, 1999) |
| "A new experimental model of acute congestive heart failure was established in open-chest dogs, and it was employed to examine the effects of dobutamine, propranolol and nitroglycerin." | 7.69 | The effects of dobutamine, propranolol and nitroglycerin on an experimental canine model of congestive heart failure. ( Kamijo, T; Kido, H; Miwa, AY; Nakamura, F; Sugimoto, T; Tomaru, T; Uchida, Y, 1994) |
| "Although arginine vasopressin (AVP) is elevated in heart failure, inhibition of the vasopressinergic V1-receptor produces minimal changes in blood pressure." | 7.68 | Attenuation of pressor responses to arginine vasopressin in right-sided congestive heart failure. ( Imai, N; Liang, CS; Sladek, CD; Stone, CK, 1990) |
| "The use of nifedipine in patients with hypertension, heart failure, and acute myocardial infarction is discussed." | 7.67 | Nifedipine in hypertension and heart failure. ( Matsui, S; Murakami, E; Murakami, H; Takekoshi, N, 1984) |
| " The resulting cardiac hypertrophy was reduced and the hypertension corrected by propranolol." | 7.67 | [The heart in patients with hypertension: effects of rilmenidine on experimental cardiac hypertrophy of hypertensive origin in rats]. ( Callens-el Amrani, F; Paolaggi, F; Swynghedauw, B, 1989) |
| "2 mg propranolol intravenously resulted in acute pulmonary edema." | 7.67 | Severe hypertension, propranolol, and acute pulmonary edema. ( Desai, SP; Fleming, TC; Pierce, EC, 1987) |
| "Although congestive heart failure has been reported with the combination of a beta blocker and either verapamil or nifedipine, it has not previously been reported for combination therapy that includes diltiazem." | 7.67 | Combination therapy with diltiazem and propranolol: precipitation of congestive heart failure. ( Egan, T; McIntyre, KM; Parisi, AF; Strauss, WE, 1985) |
| "Amrinone, a positive inotropic-vasodilator agent, was administered to anaesthetised dogs in an attempt to reverse heart failure induced by drugs possessing negative inotropic properties." | 7.67 | The beneficial effect of amrinone on acute drug-induced heart failure in the anaesthetised dog. ( Alousi, AA; Canter, JM; Fort, DJ, 1985) |
| "Hemodynamic responses to propranolol and isoproterenol were examined in elderly patients with heart failure." | 7.66 | Studies on heart failure in old age (Part II). Hemodynamic effects of propranolol and isoproterenol in elderly patients with heart failure. ( Mifune, J, 1978) |
| "Sixty-three patients with stable, severe typical angina pectoris (New York Heart Association functional class III or IV) were treated with propranolol and studied prospectively with a follow-up period of 5 to 8 years to assess the rate of complications and long-term effectiveness after an initial control period." | 7.65 | Long-term propranolol therapy for angina pectoris. ( Brewer, DL; Orgain, ES; Warren, SG, 1976) |
| "Twenty-six patients were selected for treatment with minoxidil on the basis of hypertension which could not be controlled either because of (1) drug failures and/or (2) side effects of drugs." | 7.65 | Minoxidil in severe hypertension: value when conventional drugs have failed. ( Dormois, JC; Nies, AS; Young, JL, 1975) |
| "Propranolol, which is a low-cost drug, has not been fully studied in this setting." | 6.70 | Use of propranolol in heart failure patients: safety, tolerability, and effects on left ventricular function. ( Maia, ER; Mesquita, ET; Munhoz, C; Romêo Filho, LJ; Subietta, CG; Villacorta, H, 2001) |
| "Peak reactive hyperemia (mL." | 6.68 | Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure. ( Bijou, R; Demopoulos, L; Gentilucci, M; Jones, M; Katz, SD; LeJemtel, TH; Mancini, D; Testa, M; Yeh, M, 1997) |
| "Infantile hepatic hemangioma is the most common benign liver tumor during infancy." | 6.48 | Multifocal infantile hepatic hemangiomas--imaging strategy and response to treatment after propranolol and steroids including review of the literature. ( Bosemani, T; Huisman, TA; Puttgen, KB; Tekes, A, 2012) |
| "In propranolol-treated rats, hypertrophy of the LV septum, papillary muscle, and right ventricle were similar to those of the infarcted control." | 5.31 | Effects of prolonged propranolol treatment on left ventricular remodeling and oxidative stress after myocardial infarction in rats. ( Bonnefont-Rousselot, D; Komajda, M; Lechat, P; Mansuy, P; Mougenot, N; Raillecove, F; Ramirez-Gil, JF, 2000) |
| "The propranolol treated animals had higher LV end-diastolic pressures (27+/-2* vs 20+/(-3 mmHg) and a more restricted LV diastolic filling pattern (increased ratio of early to late filling velocities and more rapid E wave deceleration rate)." | 5.30 | Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure. ( Douglas, PS; Katz, SE; Litwin, SE; Morgan, JP, 1999) |
| "In the basal state, rats with congestive heart failure had significantly (p less than 0." | 5.27 | Comparative effects of propranolol and nadolol on renal blood flow in normal rats and rats with congestive heart failure. ( Brenner, BM; Duchin, KL; Ichikawa, I; Pfeffer, J; Pfeffer, M, 1984) |
| "Beta-blockers have solid documentation in preventing cardiovascular complications in the treatment of hypertension; atenolol, metoprolol, oxprenolol and propranolol demonstrate proven cardiovascular prevention in hypertension mega-trials." | 5.22 | Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified. ( Esler, M; Grassi, G; Kjeldsen, SE; Kreutz, R; Mancia, G; Pathak, A, 2022) |
| "HRV was analysed in 14 infants with severe heart failure due to CHD who received a 'standard' therapy with digoxin and diuretics ('Digoxin/Diuretics' group) and in 9 of these patients with an additional propranolol therapy ('Propranolol' group) 17 days later on average and compared with HRV of 70 healthy infants ('Healthy Control')." | 5.10 | Heart rate variability in infants with heart failure due to congenital heart disease: reversal of depressed heart rate variability by propranolol. ( Buchhorn, R; Hulpke-Wette, M; Nothroff, J; Paul, T, 2002) |
| "This study evaluated the effects of propranolol on recovery of heart rate variability (HRV) after acute myocardial infarction and its relation to outcome in the Beta-blocker Heart Attack Trial (BHAT)." | 5.10 | Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial. ( Horwitz, RI; Ickovics, JR; Lampert, R; Lee, FA; Viscoli, CJ, 2003) |
| " We compared the data from 8 infants with severe congestive heart failure due to left-to-right shunts, who received digoxin and diuretics alone, to 9 infants who received additional treatment with propranolol." | 5.10 | Effects of therapeutic beta blockade on myocardial function and cardiac remodelling in congenital cardiac disease. ( Buchhorn, R; Fielitz, J; Hetzer, R; Hulpke-Wette, M; Pregla, R; Regitz-Zagrosek, V; Ross, RD; Ruschewski, W, 2003) |
| " Beta-receptor gene expression in 16 children who received standard treatment for heart failure averaged lower than in the 10 children who received additional propranolol." | 5.10 | Beta-receptor downregulation in congenital heart disease: a risk factor for complications after surgical repair? ( Buchhorn, R; Fielitz, J; Hetzer, R; Hulpke-Wette, M; Pregla, R; Regitz-Zagrosek, V; Ruschewski, W, 2002) |
| " After 17 days on average beta-blocker treated infants (propranolol:1,6 mg/kg/day) improved significantly with respect to Ross heart failure score (3." | 5.09 | Propranolol treatment of congestive heart failure in infants with congenital heart disease: The CHF-PRO-INFANT Trial. Congestive heart failure in infants treated with propanol. ( Bartmus, D; Buchhorn, R; Bürsch, J; Hilgers, R; Hulpke-Wette, M; Wessel, A, 2001) |
| "The Danish Verapamil Infarction Trial II (DAVIT II) demonstrated from the second postinfarction week, that long term treatment with verapamil significantly improved reinfarction free survival after an acute myocardial infarction (AMI)." | 5.08 | Effect of verapamil on the prognosis of patients with early postinfarction electrical or mechanical complications. The Danish Verapamil Infarction Trial II (DAVIT II). ( Hagerup, L; Hansen, JF; Mellemgaard, K; Sigurd, B; Steinmetz, E; Vaage-Nilsen, M, 1995) |
| "At 32-month follow-up of older patients with prior myocardial infarction, congestive heart failure, and a left ventricular ejection fraction > or = 40% treated with diuretics plus angiotensin-converting enzyme inhibitors, and also with digoxin if atrial fibrillation was present, propranolol caused a 35% significant reduction in total mortality and a 37% significant decrease in total mortality plus nonfatal myocardial infarction compared with no propranolol." | 5.08 | Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus ( Ahn, C; Aronow, WS; Kronzon, I, 1997) |
| "To develop a strategy for evaluating drug efficacy over time that accounts for heterogeneous clinical courses evolving after initiation of therapy and to demonstrate its use in assessing the long-term therapeutic benefit of propranolol after myocardial infarction." | 5.07 | Beta-blockers after myocardial infarction: influence of first-year clinical course on long-term effectiveness. ( Horwitz, RI; Singer, BH; Viscoli, CM, 1993) |
| "The incidence of congestive heart failure was studied in the Beta Blocker Heart Attack Trial in which postmyocardial infarction patients between the ages of 30 and 69 years, with no contraindication to propranolol, were randomly assigned to receive placebo (n = 1921) or propranolol 180 or 240 mg daily (n = 1916) 5 to 21 days after admission to the hospital for the event." | 5.06 | Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. ( Byington, R; Chadda, K; Curb, JD; Goldstein, S, 1986) |
| "The beta-Blocker Heart Attack Trial (BHAT) was a placebo-controlled, randomized, double-blind clinical trial of the long-term administration of propranolol hydrochloride to persons who had had at least one confirmed myocardial infarction." | 5.05 | A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results. ( , 1983) |
| " Patients suffering from congestive heart failure were treated with Digitalis, other patients with normal hearts were subjected to infusion therapy of Isoproterenol, Propranolol, Verapamil and Calcium chloride." | 5.04 | [Echocardiographic evaluation of left ventricular function during therapy with cardiovascularly effective drugs]. ( Stefan, G, 1976) |
| "Multiclinic controlled studies have shown that enalapril alone 10 to 40 mg/day orally is effective in lowering blood pressure in patients with essential hypertension." | 4.77 | Enalapril in hypertension and congestive heart failure. Overall review of efficacy and safety. ( Davies, RO; Moncloa, F; Sromovsky, JA; Walker, JF, 1985) |
| "To assess the efficacy of transcatheter arterial embolization (TAE) plus propranolol treatment for infantile hepatic hemangioma (IHH)." | 4.12 | Clinical evaluation of transcatheter arterial embolization combined with propranolol orally treatment of infantile hepatic hemangioma. ( Guo, L; Li, J; Song, D; Wang, L, 2022) |
| "Transcatheter arterial embolization combined with propranolol is an effective treatment for life-threatening infantile hepatic hemangioendothelioma." | 3.96 | Infantile hepatic hemangioendothelioma associated with pulmonary artery hypertension and cardiac insufficiency successfully treated with transcatheter arterial embolization and propranolol: A case report. ( Guo, L; Li, J; Song, D; Wang, L; Wu, C; Yin, J, 2020) |
| " Three weeks after inducing myocardial infarction (MI), rats were treated daily with or without 20 and 75 mg/kg atenolol, a selective β(1) -AR antagonist, or propranolol, a non-selective β-AR antagonist, for 5 weeks." | 3.77 | β-adrenergic blockade attenuates cardiac dysfunction and myofibrillar remodelling in congestive heart failure. ( Dhalla, NS; Elimban, V; Machackova, J; Sanganalmath, SK, 2011) |
| "We report the rapid and dramatic efficacy of propranolol in 8 infants with infantile hepatic hemangiomas." | 3.76 | Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. ( Ammour, A; Benlahrech, S; Bodemer, C; Broue, P; Hoeger, PH; Labenne, M; Léauté-Labrèze, C; Mazereeuw-Hautier, J; Ohanessian, G; Rössler, J; Vabres, P; Vial, J, 2010) |
| "Large clinical trials using the betablockers carvedilol, metoprolol, bisoprolol and nebivolol have demonstrated improvement of survival and symptoms in patients with heart failure." | 3.76 | Replacement of carvedilol for propranolol in patients with heart failure. ( Castro, RB; Gallo, L; Maciel, BC; Marques, F; Nobre, F; Pintya, AO; Simões, MV, 2010) |
| "Heart failure (HF) may be produced by sustained beta-adrenoceptor stimulation by causing changes in the expression of endothelin-1 (ET-1), the leptin system, calcineurin and sarcoplasmic reticulum Ca2+ ATPase 2a (SERCA2a) underlying cardiac dysfunction." | 3.74 | Protective effect of the endothelin antagonist CPU0213 against isoprenaline-induced heart failure by suppressing abnormal expression of leptin, calcineurin and SERCA2a in rats. ( Dai, DZ; Dai, Y; Ji, H; Tang, XY; Xu, M, 2008) |
| "To understand the basis of the effectiveness of carvedilol in heart failure by determining its specific properties at human heart beta1- and beta2-adrenoceptors." | 3.73 | Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart. ( Christ, T; Kaumann, A; Molenaar, P; Ravens, U, 2006) |
| " To assess whether these differential structural effects do translate into different effects on LV function and on heart failure mortality, Bd or sham Bd 8-week-old rats were randomized to vehicle treatment (Vh), chemical sympathectomy ([Sx] 6-hydroxydopamine, 150 mg/kg IP twice a week), beta-adrenoceptor blockade (propranolol [Pro], 40 mg/kg per day PO), or alpha-adrenoceptor blockade (doxazosin [Dox], 5 mg/kg per day PO)." | 3.73 | Survival benefits of different antiadrenergic interventions in pressure overload left ventricular hypertrophy/failure. ( Busca, G; Cesana, F; Clari, F; Ferrari, AU; Ferrero, I; Gatti, C; Janetti, MB; Mancia, G; Palladini, G; Perlini, S; Tozzi, R; Vezzoli, M, 2006) |
| "In contrast to other beta-blockers, bucindolol has failed to reduce mortality in patients with chronic heart failure." | 3.72 | Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor. ( Böhm, M; Dabew, E; Engelhardt, S; Lohse, MJ; Lorenz, K; Maack, C; Schäfers, HJ; Vlaskin, L, 2003) |
| " Prenatal treatment with beta-adrenergic blocker (propranolol) and digitalis glycosides was prescribed because of suspicion of long QT syndrome occurring with fetal congestive heart failure." | 3.71 | Prenatal diagnosis and treatment of fetal long QT syndrome: a case report. ( Chang, IK; Chow, SN; Hsieh, FJ; Kau, ML; Ko, YH; Lee, CN; Shyu, MK, 2002) |
| "We report on the clinical and neurohumoral effects of adding low-dose propranolol to conventional therapy with digoxin and diuretics in 6 infants with severe congestive heart failure due to large left-to-right shunts." | 3.70 | Beta-blocker therapy of severe congestive heart failure in infants with left to right shunts. ( Bartmus, D; Buchhorn, R; Bürsch, J; Hulpke-Wette, M; Schulz, R; Siekmeyer, W, 1998) |
| "Fifteen patients with heart failure and using propranolol were assessed over a period of 12 months." | 3.70 | Effects of propranolol on the QT dispersion in congestive heart failure. ( Cramer, H; de Deus, FC; dos Santos, PA; dos Santos, VB; Guedes, CR; Maia, ER; Mesquita, ET; Romeo, LJ; Subieta, CG; Villacorta, H, 1999) |
| "A new experimental model of acute congestive heart failure was established in open-chest dogs, and it was employed to examine the effects of dobutamine, propranolol and nitroglycerin." | 3.69 | The effects of dobutamine, propranolol and nitroglycerin on an experimental canine model of congestive heart failure. ( Kamijo, T; Kido, H; Miwa, AY; Nakamura, F; Sugimoto, T; Tomaru, T; Uchida, Y, 1994) |
| " At a final experiment, acute cardiac failure was induced by administration of propranolol." | 3.69 | Hemodynamic effects of different pacing ratios in chronic dynamic double cardiomyoplasty. ( Earle, NR; Glaeser, DH; Hartley, CJ; Lawrie, GM; Li, Z; Michael, LH; Soltero, ER, 1996) |
| " Eight anesthetized open chest dogs suffering from atrial fibrillation and heart failure, obtained by topic acetylcholine and propranolol, were treated by a cardiomyoplasty procedure performed with an electrostimulated latissimus dorsi muscle flap (LDMF)." | 3.69 | Hemodynamic effects of cardiomyoplasty in an experimental model of acute heart failure and atrial fibrillation. ( Cabrera Fischer, EI; Carpentier, A; Chachques, JC; Christen, AI; Risk, MR, 1996) |
| "Cardiac failure regressed and thyroid function normalized within ten days on propranolol, 4 x 40 mg and thiamazole 3 x 40 mg daily intravenously." | 3.69 | [Immunogenic hyperthyroidism with hyperdynamic heart failure and early cirrhotic transformation of the liver]. ( Fischer, MR; Gärtner, R; Huss, R; Spes, CH, 1997) |
| "The use of propranolol is generally contraindicated in patients with congestive heart failure." | 3.68 | Successful treatment of life-threatening ventricular tachycardia with high-dose propranolol under extracorporeal life support and intraaortic balloon pumping. ( Goto, H; Kurose, M; Ogata, K; Okamoto, K; Okumura, K; Sato, T; Terasaki, H; Yasumoto, M; Yatsuda, R, 1993) |
| ") of 13 tended to decrease left ventricular end-diastolic pressure (LVEDP) in a propranolol-induced heart failure model (dogs) and showed a potent protective effect against reperfusion arrhythmia in rats." | 3.68 | 1,4:3,6-Dianhydrohexitol nitrate derivatives. I. Synthesis and antianginal activity of alkylpiperazine derivatives. ( Hayashi, H; Ikeda, J; Kubo, K; Kuroda, T; Sano, T; Suzuki, F, 1993) |
| " A significant reversal of cardiac failure was attained in anaesthetised dogs subjected to propranolol induced cardiac insufficiency." | 3.68 | Cardiotonic activity of the water soluble forskolin derivative 8,13-epoxy-6 beta-(piperidinoacetoxy)- 1 alpha, 7 beta, 9 alpha-trihydroxy-labd- 14en-11-one. ( Ghate, AV; Linz, W; Rajagopalan, R; Schoelkens, BA; Subbarayan, P, 1993) |
| " Propranolol treatment improved basal isometric muscle function and beta-adrenergic receptor density in rats after myocardial infarction but did not improve adenylate cyclase activity or isoproterenol-stimulated muscle function." | 3.68 | Effects of beta-adrenergic blockade on papillary muscle function and the beta-adrenergic receptor system in noninfarcted myocardium in compensated ischemic left ventricular dysfunction. ( Bellah, KL; Goldman, S; Raya, TE; Roeske, WR; Warner, AL, 1992) |
| "The efficacy of a controlled-release topical dosage form of glyceryl trinitrate (Nitroglycerin Transdermal Therapeutic System, Nitroderm TTS, NTG-TTS; CAS 55-63-0) was studied in the experimental model of congestive heart failure in beagles." | 3.68 | Efficacy of the glyceryl trinitrate transdermal therapeutic system in a dog model of heart failure. ( Inukai, T; Katahira, J; Nakao, K; Tanaka, M, 1991) |
| " The CAD was implanted near the aortic root of five dogs, in whom cardiac failure was induced through the use of propranolol and plasma expanders." | 3.68 | [Circulatory assist device in counterpulsation]. ( Jatene, AD; Lage, SG; Leirner, AA; Marques, E; Ribeiro, MP, 1990) |
| "Although arginine vasopressin (AVP) is elevated in heart failure, inhibition of the vasopressinergic V1-receptor produces minimal changes in blood pressure." | 3.68 | Attenuation of pressor responses to arginine vasopressin in right-sided congestive heart failure. ( Imai, N; Liang, CS; Sladek, CD; Stone, CK, 1990) |
| "The use of nifedipine in patients with hypertension, heart failure, and acute myocardial infarction is discussed." | 3.67 | Nifedipine in hypertension and heart failure. ( Matsui, S; Murakami, E; Murakami, H; Takekoshi, N, 1984) |
| " In the acute heart failure models induced by either propranolol or pentobarbital, MS-857 reversed the cardiac depressant effects of these drugs." | 3.67 | Cardiovascular properties of MS-857, a new and potent cardiotonic agent, on normal and failing hearts. ( Kaiho, T; Kamiya, J; Kobari, T; Maruyama, M, 1988) |
| " The resulting cardiac hypertrophy was reduced and the hypertension corrected by propranolol." | 3.67 | [The heart in patients with hypertension: effects of rilmenidine on experimental cardiac hypertrophy of hypertensive origin in rats]. ( Callens-el Amrani, F; Paolaggi, F; Swynghedauw, B, 1989) |
| "Arginine vasopressin is elevated in congestive heart failure." | 3.67 | Short-term hemodynamic effects of vasopressin V1-receptor inhibition in chronic right-sided congestive heart failure. ( Hood, WB; Imai, N; Liang, CS; Sakamoto, S; Sladek, CD; Stone, CK, 1988) |
| ") was effective in heart failure models induced with high doses of propranolol or verapamil." | 3.67 | Cardiovascular pharmacology of 6-[4-(4'-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride, a novel and potent cardiotonic agent with vasodilator properties. ( Kitada, Y; Narimatsu, A; Okushima, H; Satoh, N; Suzuki, R, 1987) |
| "2 mg propranolol intravenously resulted in acute pulmonary edema." | 3.67 | Severe hypertension, propranolol, and acute pulmonary edema. ( Desai, SP; Fleming, TC; Pierce, EC, 1987) |
| " Quinidine, procainamide, lidocaine, and propranolol are used to treat a variety of supraventricular and ventricular arrhythmias." | 3.67 | Pharmacology and pharmacokinetics of drugs used to treat cardiac disease in horses. ( McGuirk, SM; Muir, WW, 1985) |
| "Although congestive heart failure has been reported with the combination of a beta blocker and either verapamil or nifedipine, it has not previously been reported for combination therapy that includes diltiazem." | 3.67 | Combination therapy with diltiazem and propranolol: precipitation of congestive heart failure. ( Egan, T; McIntyre, KM; Parisi, AF; Strauss, WE, 1985) |
| "Amrinone, a positive inotropic-vasodilator agent, was administered to anaesthetised dogs in an attempt to reverse heart failure induced by drugs possessing negative inotropic properties." | 3.67 | The beneficial effect of amrinone on acute drug-induced heart failure in the anaesthetised dog. ( Alousi, AA; Canter, JM; Fort, DJ, 1985) |
| "Hemodynamic responses to propranolol and isoproterenol were examined in elderly patients with heart failure." | 3.66 | Studies on heart failure in old age (Part II). Hemodynamic effects of propranolol and isoproterenol in elderly patients with heart failure. ( Mifune, J, 1978) |
| "Sixty-three patients with stable, severe typical angina pectoris (New York Heart Association functional class III or IV) were treated with propranolol and studied prospectively with a follow-up period of 5 to 8 years to assess the rate of complications and long-term effectiveness after an initial control period." | 3.65 | Long-term propranolol therapy for angina pectoris. ( Brewer, DL; Orgain, ES; Warren, SG, 1976) |
| "50 patients with stenocardias in persisting arterial hypertension, of them 33 manifest coronary diseases, were orally treated with doses of propranolol up to 400 mg/die during a longer period." | 3.65 | [Therapy of chronic ischemic heart disease and arterial hypertension by means of beta-receptor blockaders]. ( Dück, K; Knappe, J; Strube, G, 1976) |
| "Twenty-six patients were selected for treatment with minoxidil on the basis of hypertension which could not be controlled either because of (1) drug failures and/or (2) side effects of drugs." | 3.65 | Minoxidil in severe hypertension: value when conventional drugs have failed. ( Dormois, JC; Nies, AS; Young, JL, 1975) |
| "Propranolol, which is a low-cost drug, has not been fully studied in this setting." | 2.70 | Use of propranolol in heart failure patients: safety, tolerability, and effects on left ventricular function. ( Maia, ER; Mesquita, ET; Munhoz, C; Romêo Filho, LJ; Subietta, CG; Villacorta, H, 2001) |
| "Peak reactive hyperemia (mL." | 2.68 | Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure. ( Bijou, R; Demopoulos, L; Gentilucci, M; Jones, M; Katz, SD; LeJemtel, TH; Mancini, D; Testa, M; Yeh, M, 1997) |
| "There is not enough evidence to support or discourage the use of beta-blockers in children with congestive heart failure, or to propose a paediatric dosing scheme." | 2.66 | Beta-blockers for congestive heart failure in children. ( Al Dakhoul, S; Alabed, S; Bdaiwi, Y; Sabouni, A, 2020) |
| "The incidences of congestive heart failure, hypotension, AV blocks and ventricular arrhythmias were not significantly more common in the control group (8 vs." | 2.65 | Established beta-adrenergic receptor blocking therapy and acute myocardial infarction. A clinical study of risks and benefits. ( Berglund, U; Dahlström, U; Karlsson, E, 1980) |
| "There is not enough evidence to support or discourage the use of beta-blockers in children with congestive heart failure, or to propose a paediatric dosing scheme." | 2.53 | Beta-blockers for congestive heart failure in children. ( Al Dakhoul, S; Alabed, S; Bdaiwi, Y; Frobel-Mercier, AK; Sabouni, A, 2016) |
| "Infantile hepatic hemangioma is the most common benign liver tumor during infancy." | 2.48 | Multifocal infantile hepatic hemangiomas--imaging strategy and response to treatment after propranolol and steroids including review of the literature. ( Bosemani, T; Huisman, TA; Puttgen, KB; Tekes, A, 2012) |
| "In patients with dilated cardiomyopathy the beta-adrenergic responsiveness of the myocardium is diminished." | 2.41 | The beta-adrenergic receptors. ( Wallukat, G, 2002) |
| " Numerous questions concerning the exact indications of these drugs, the nature and dosage of the beta-blocker to be used, the possible combinations with other therapies and the responses to be expected remain to be answered." | 2.38 | [Beta-blockers in the treatment of heart failure]. ( Grosgogeat, Y; Komajda, M; Lechat, P; Salloum, J, 1990) |
| "Chorea was successfully treated with pulse methylprednisolone." | 1.91 | Coexistence of Graves' disease with acute rheumatic fever treated as thyroid storm in young Thai patient. ( Aroonparkmongkol, S; Onsoi, W; Srilanchakon, K; Supornsilchai, V, 2023) |
| "Consumptive hypothyroidism is a rare paraneoplastic syndrome characterized by excessive inactivation of the thyroid hormones due to increased type 3 iodothyronine deiodinase activity of tumors." | 1.56 | A Case of Consumptive Hypothyroidism in a 1-Month-Old Boy with Diffuse Infantile Hepatic Hemangiomas. ( Hong, KT; Kim, GB; Kim, YH; Ko, JS; Lee, YA; Lee, YJ; Shin, CH, 2020) |
| "Neonatal hyperthyroidism is usually a self-limited condition frequently associated with transplacental passage of thyroid stimulating antibodies secondary to maternal autoimmune disorders." | 1.40 | [Heart failure as early manifestation of neonatal hyperthyroidism. Case report]. ( Alvarado S, JL; Fernández V, ZA, 2014) |
| "Amphotericin B was the only other antifungal that demonstrated a 2D SDR with CHF-related events." | 1.39 | A quantitative analysis of the spontaneous reporting of congestive heart failure-related adverse events with systemic anti-fungal drugs. ( Hauben, M; Hung, EY, 2013) |
| " Hepatic pharmacokinetic modelling was performed with a two-phase physiologically-based organ pharmacokinetic model with the vascular space and dispersion evaluated with the MID technique." | 1.38 | Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage. ( Crawford, DH; Fletcher, LM; Li, P; Roberts, MS; Robertson, TA; Weiss, M; Zhang, Q, 2012) |
| "With aggressive treatment of the heart failure and hyperthyroid state, her dyspnea, pleural effusion, chylous ascites, and edema resolved completely within a few days." | 1.36 | Chylous ascites as a manifestation of thyrotoxic cardiomyopathy in a patient with untreated Graves' disease. ( Chang, CT; Chen, CC; Hsieh, MH; Wang, TY, 2010) |
| "The treatment with propranolol, corticosteroids and diuretics was successful." | 1.35 | [Young woman with hyperthyroidism associated with severe tricuspid regurgitation]. ( González, DR; Petrucci, E; Pisarevsky, AA; Saad, AK; Vázquez Blanco, M, 2008) |
| "Recurrent life-threatening episodes of ventricular tachycardia persisted despite maximal antiarrhythmic theraphy with amiodarone, metoprolol and mexiletine." | 1.33 | Suppression by propranolol and amiodarone of an electrical storm refractory to metoprolol and amiodarone. ( Anastasiou-Nana, MI; Kanakakis, J; Rokas, S; Tsagalou, EP, 2005) |
| "Propranolol treatment of TOT mice reversed the alterations in SERCA and NCX protein levels but not potassium channels." | 1.32 | Calcium dynamics in the failing heart: restoration by beta-adrenergic receptor blockade. ( Benkusky, N; Fiset, C; Glascock, B; Lalli, MJ; Periasamy, M; Plank, DM; Ritsu, H; Sussman, MA; Valdivia, HH; Witt, S; Yatani, A, 2003) |
| "Congestive heart failure is associated with a loss of circadian and short-term variability in blood pressure and heart rate." | 1.32 | Circadian and short-term regulation of blood pressure and heart rate in transgenic mice with cardiac overexpression of the beta1-adrenoceptor. ( Engelhardt, S; Janssen, BJ; Lemmer, B; Lohse, M; Witte, K, 2004) |
| "In propranolol-treated rats, hypertrophy of the LV septum, papillary muscle, and right ventricle were similar to those of the infarcted control." | 1.31 | Effects of prolonged propranolol treatment on left ventricular remodeling and oxidative stress after myocardial infarction in rats. ( Bonnefont-Rousselot, D; Komajda, M; Lechat, P; Mansuy, P; Mougenot, N; Raillecove, F; Ramirez-Gil, JF, 2000) |
| "Ventricular arrhythmias and contractile dysfunction are the main causes of death in human heart failure (HF)." | 1.31 | Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness. ( Bers, DM; Li, L; Pogwizd, SM; Schlotthauer, K; Yuan, W, 2001) |
| "The propranolol treated animals had higher LV end-diastolic pressures (27+/-2* vs 20+/(-3 mmHg) and a more restricted LV diastolic filling pattern (increased ratio of early to late filling velocities and more rapid E wave deceleration rate)." | 1.30 | Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure. ( Douglas, PS; Katz, SE; Litwin, SE; Morgan, JP, 1999) |
| "DL-Sotalol has class III antiarrhythmic activity through prolongation of the repolarization phase of the action potential as well as beta-adrenoceptor-blocking properties." | 1.29 | Positive and negative inotropic effects of DL-sotalol and D-sotalol in failing and nonfailing human myocardium under physiological experimental conditions. ( Fraedrich, G; Hasenfuss, G; Holubarsch, C; Just, H; Pieske, B; Posival, H; Ruf, T; Schneider, R, 1995) |
| "Dopexamine is a synthetic catecholamine with predominantly beta 2 and dopaminergic adrenergic receptor activities." | 1.29 | Effects of dopexamine on hemodynamics and oxygen consumption after beta blockade in lambs. ( Rogers, BW; Sziszak, TJ; Sziszak, TL; Taylor, BJ, 1993) |
| "Propranolol was preferred to diltiazem for treating feline hypertrophic cardiomyopathy." | 1.29 | Preferences of veterinarians for drugs to treat heart disease in dogs and cats. ( Church, DB; Watson, AD, 1995) |
| "Chronic treatment of heart failure patients with beta-adrenoceptor antagonists leads to an up-regulation of cardiac beta-adrenoceptors, but in a subtype-selective fashion: beta 1-selective antagonists increase only cardiac beta 1-adrenoceptors, whereas non-selective antagonists increase both beta 1- and beta 2-adrenoceptors." | 1.28 | Drug- and disease-induced changes of human cardiac beta 1- and beta 2-adrenoceptors. ( Borst, HG; Brodde, OE; Maier, W; Michel, MC; Zerkowski, HR, 1989) |
| "Young turkeys inbred for congestive cardiomyopathy (CCM) were treated with propranolol prior to the development of cardiac enlargement." | 1.27 | Effect of early propranolol treatment in an animal model of congestive cardiomyopathy. II. beta-adrenergic receptors and left ventricular function. ( Einzig, S; Noren, GR; Rublein, TG; Staley, NA, 1984) |
| "In the basal state, rats with congestive heart failure had significantly (p less than 0." | 1.27 | Comparative effects of propranolol and nadolol on renal blood flow in normal rats and rats with congestive heart failure. ( Brenner, BM; Duchin, KL; Ichikawa, I; Pfeffer, J; Pfeffer, M, 1984) |
| "Propranolol treated inbred birds showed a significantly reduced mortality from 5 to 15 days of age when compared with untreated inbred birds." | 1.27 | Effect of early propranolol treatment in an animal model of congestive cardiomyopathy: I Mortality and Ca2+ transport in sarcoplasmic reticulum. ( Einzig, S; Noren, GR; Rublein, TG; Staley, NA, 1984) |
| "Milrinone (Win 47203) is a dipyridine related to amrinone, which is about 20-50 times as effective as amrinone when assayed on cardiac contractility." | 1.27 | The search for a digitalis substitute II milrinone (Win 47203). Its action on the heart-lung preparation of the dog. ( Farah, A; Kabela, E; Mendez, R; Pastelin, G, 1983) |
| "Enalapril is an inhibitor of the converting enzyme which transforms angiotensin I into angiotensin II, an octapeptide with pharmacological properties uniformly tending to increase blood pressure." | 1.27 | [Clinical pharmacology of enalapril]. ( Giudicelli, JF, 1985) |
| "Coexisting cardiac arrhythmia had no influence on prognosis and an arrhythmia only was benign in most patients." | 1.26 | Primary myocardial disease. Correlation with clinical findings, angiographic and biopsy diagnosis. Follow-up of 139 patients. ( Hawk, WA; Proudfit, WL; Shirey, EK, 1980) |
| "Cardiomegaly was seen in 9/23 patients with nocturnal angina and 22/141 without (p less than 0." | 1.26 | Significance and treatment of nocturnal angina preceding myocardial infarction. ( Alosilla, C; Chadda, KD; Gupta, PK; Lichstein, E, 1977) |
| "In half of the patients with tachyarrhythmia." | 1.26 | [Treatment of acute left-ventricular insufficiency complicated by tachyarrhythmia under conditions of cardiological emergency service]. ( Danilenko, AM; Rodionov, VM; Zakharova, RM, 1979) |
| "In patients with thyrotoxic cardiac failure the resting cardiac output was normal, but it fell after propranolol by 30% to subnormal levels." | 1.26 | Haemodynamic effects of beta-adrenergic blockade in hyperthyroid patients with and without heart failure. ( Ikram, H, 1977) |
| "The natural history of 14 patients with ventricular septal defect and right-sided aortic arch is reviewed." | 1.25 | Natural history of ventricular septal defect with right-sided aortic arch. ( Allen, JR; Rosenquist, GC; Rowe, RD; Varghese, PJ, 1970) |
| "About 7% died from cardiac arrhythmia four days or more after the onset of infarction." | 1.25 | Hospital mortality in acute myocardial infarction. ( Bensley, KE; Caughey, DE; Norris, RM; Scott, PJ, 1968) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 214 (66.46) | 18.7374 |
| 1990's | 43 (13.35) | 18.2507 |
| 2000's | 35 (10.87) | 29.6817 |
| 2010's | 23 (7.14) | 24.3611 |
| 2020's | 7 (2.17) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, L | 2 |
| Li, J | 2 |
| Song, D | 2 |
| Guo, L | 2 |
| Esler, M | 1 |
| Kjeldsen, SE | 1 |
| Pathak, A | 1 |
| Grassi, G | 1 |
| Kreutz, R | 1 |
| Mancia, G | 2 |
| Onsoi, W | 1 |
| Srilanchakon, K | 1 |
| Aroonparkmongkol, S | 1 |
| Supornsilchai, V | 1 |
| Kim, YH | 1 |
| Lee, YA | 1 |
| Shin, CH | 1 |
| Hong, KT | 1 |
| Kim, GB | 1 |
| Ko, JS | 1 |
| Lee, YJ | 1 |
| Wu, C | 1 |
| Yin, J | 1 |
| Alabed, S | 2 |
| Sabouni, A | 2 |
| Al Dakhoul, S | 2 |
| Bdaiwi, Y | 2 |
| Zhou, H | 1 |
| Sim, JJ | 1 |
| Shi, J | 1 |
| Shaw, SF | 1 |
| Lee, MS | 2 |
| Neyer, JR | 1 |
| Kovesdy, CP | 1 |
| Kalantar-Zadeh, K | 1 |
| Jacobsen, SJ | 1 |
| Duan, L | 1 |
| Ng, A | 1 |
| Chen, W | 1 |
| Spencer, HT | 1 |
| Nguyen, J | 1 |
| Shen, AY | 1 |
| Tyrrell, C | 1 |
| Toyooka, A | 1 |
| Khan, F | 1 |
| Thornburg, KL | 1 |
| Mudd, JO | 1 |
| Hasan, W | 1 |
| Stark, C | 1 |
| Kiss, J | 1 |
| Lemström, K | 1 |
| Hauben, M | 1 |
| Hung, EY | 1 |
| Vasudevan, NT | 1 |
| Mohan, ML | 1 |
| Gupta, MK | 1 |
| Martelli, EE | 1 |
| Hussain, AK | 1 |
| Qin, Y | 1 |
| Chandrasekharan, UM | 1 |
| Young, D | 1 |
| Feldman, AM | 2 |
| Sen, S | 1 |
| Dorn, GW | 2 |
| Dicorleto, PE | 1 |
| Naga Prasad, SV | 1 |
| Alvarado S, JL | 1 |
| Fernández V, ZA | 1 |
| Frobel-Mercier, AK | 1 |
| Nikolla, DA | 1 |
| Carlson, JN | 1 |
| Léauté-Labrèze, C | 2 |
| Harper, JI | 1 |
| Hoeger, PH | 2 |
| Tanel, RE | 1 |
| Sal'nikov, EV | 1 |
| Leppikangas, H | 1 |
| Ruokonen, E | 1 |
| Rutanen, J | 1 |
| Kiviniemi, V | 1 |
| Lindgren, L | 1 |
| Kurola, J | 1 |
| Machackova, J | 2 |
| Sanganalmath, SK | 2 |
| Barta, J | 1 |
| Dhalla, KS | 1 |
| Dhalla, NS | 2 |
| Elimban, V | 1 |
| Lugassy, DM | 1 |
| Stefan, A | 1 |
| Dexeus, D | 1 |
| Hoffman, RS | 1 |
| Nelson, LS | 1 |
| Hsieh, MH | 1 |
| Chen, CC | 1 |
| Wang, TY | 1 |
| Chang, CT | 1 |
| Mazereeuw-Hautier, J | 1 |
| Benlahrech, S | 1 |
| Ammour, A | 1 |
| Broue, P | 1 |
| Vial, J | 1 |
| Ohanessian, G | 1 |
| Labenne, M | 1 |
| Vabres, P | 1 |
| Rössler, J | 1 |
| Bodemer, C | 1 |
| Marques, F | 1 |
| Castro, RB | 1 |
| Nobre, F | 1 |
| Pintya, AO | 1 |
| Gallo, L | 1 |
| Maciel, BC | 1 |
| Simões, MV | 1 |
| Guo, D | 1 |
| Kassiri, Z | 1 |
| Basu, R | 1 |
| Chow, FL | 1 |
| Kandalam, V | 1 |
| Damilano, F | 1 |
| Liang, W | 1 |
| Izumo, S | 1 |
| Hirsch, E | 1 |
| Penninger, JM | 1 |
| Backx, PH | 1 |
| Oudit, GY | 1 |
| Sugai, TK | 1 |
| Tanaka, A | 1 |
| Yoshizawa, M | 1 |
| Shiraishi, Y | 1 |
| Baba, A | 1 |
| Yambe, T | 1 |
| Nitta, S | 1 |
| McMurray, JJ | 1 |
| Cheng, G | 1 |
| Kasiganesan, H | 1 |
| Baicu, CF | 1 |
| Wallenborn, JG | 1 |
| Kuppuswamy, D | 1 |
| Cooper, G | 1 |
| Bosemani, T | 1 |
| Puttgen, KB | 1 |
| Huisman, TA | 1 |
| Tekes, A | 1 |
| Li, P | 1 |
| Robertson, TA | 1 |
| Zhang, Q | 1 |
| Fletcher, LM | 1 |
| Crawford, DH | 1 |
| Weiss, M | 1 |
| Roberts, MS | 1 |
| Kamalanathan, S | 1 |
| Balachandran, K | 1 |
| Packirisamy, G | 1 |
| Hamide, A | 1 |
| Mircoli, L | 1 |
| Fedele, L | 1 |
| Benetti, M | 1 |
| Bolla, GB | 1 |
| Radaelli, A | 1 |
| Perlini, S | 2 |
| Ferrari, AU | 2 |
| Buchhorn, R | 6 |
| Hulpke-Wette, M | 6 |
| Nothroff, J | 1 |
| Paul, T | 1 |
| Bruns, LA | 1 |
| Canter, CE | 1 |
| Wallukat, G | 1 |
| Chang, IK | 1 |
| Shyu, MK | 1 |
| Lee, CN | 1 |
| Kau, ML | 1 |
| Ko, YH | 1 |
| Chow, SN | 1 |
| Hsieh, FJ | 1 |
| Lampert, R | 1 |
| Ickovics, JR | 1 |
| Viscoli, CJ | 1 |
| Horwitz, RI | 2 |
| Lee, FA | 1 |
| Plank, DM | 1 |
| Yatani, A | 1 |
| Ritsu, H | 1 |
| Witt, S | 1 |
| Glascock, B | 1 |
| Lalli, MJ | 1 |
| Periasamy, M | 1 |
| Fiset, C | 1 |
| Benkusky, N | 1 |
| Valdivia, HH | 1 |
| Sussman, MA | 1 |
| Ruschewski, W | 2 |
| Ross, RD | 1 |
| Fielitz, J | 2 |
| Pregla, R | 2 |
| Hetzer, R | 2 |
| Regitz-Zagrosek, V | 2 |
| Eleftheriadis, D | 1 |
| Fourla, E | 1 |
| Eleftheriadis, N | 1 |
| Vrizidis, P | 1 |
| Fourlas, C | 1 |
| Maack, C | 1 |
| Böhm, M | 2 |
| Vlaskin, L | 1 |
| Dabew, E | 1 |
| Lorenz, K | 1 |
| Schäfers, HJ | 1 |
| Lohse, MJ | 1 |
| Engelhardt, S | 2 |
| Vasil'ev, AP | 1 |
| Strel'tsova, NN | 1 |
| Gorbunova, TIu | 1 |
| SLOMAN, G | 1 |
| ROBINSON, JS | 1 |
| MCLEAN, K | 1 |
| Witte, K | 1 |
| Janssen, BJ | 1 |
| Lohse, M | 1 |
| Lemmer, B | 1 |
| Tsagalou, EP | 1 |
| Kanakakis, J | 1 |
| Rokas, S | 1 |
| Anastasiou-Nana, MI | 1 |
| Tamagawa, K | 1 |
| Saito, T | 1 |
| Oikawa, Y | 1 |
| Maehara, K | 1 |
| Yaoita, H | 1 |
| Maruyama, Y | 1 |
| Molenaar, P | 1 |
| Christ, T | 1 |
| Ravens, U | 1 |
| Kaumann, A | 1 |
| Ferrero, I | 1 |
| Palladini, G | 1 |
| Tozzi, R | 1 |
| Gatti, C | 1 |
| Vezzoli, M | 1 |
| Cesana, F | 1 |
| Janetti, MB | 1 |
| Clari, F | 1 |
| Busca, G | 1 |
| Azzam, ZS | 1 |
| Adir, Y | 1 |
| Welch, L | 1 |
| Chen, J | 1 |
| Winaver, J | 1 |
| Factor, P | 1 |
| Krivoy, N | 1 |
| Hoffman, A | 1 |
| Sznajder, JI | 1 |
| Abassi, Z | 1 |
| Saad, AK | 1 |
| Pisarevsky, AA | 1 |
| González, DR | 1 |
| Vázquez Blanco, M | 1 |
| Petrucci, E | 1 |
| Xu, M | 1 |
| Ji, H | 1 |
| Dai, DZ | 1 |
| Tang, XY | 1 |
| Dai, Y | 1 |
| Goodyer, AV | 1 |
| Cohen, LS | 1 |
| Braunwald, E | 3 |
| Staley, NA | 2 |
| Noren, GR | 2 |
| Einzig, S | 2 |
| Rublein, TG | 2 |
| Dahlström, U | 1 |
| Berglund, U | 1 |
| Karlsson, E | 1 |
| Moses, JW | 1 |
| Borer, JS | 1 |
| O'Rourke, RA | 1 |
| Badke, FR | 1 |
| Forst, D | 1 |
| Jentsch, G | 1 |
| Weber, KT | 2 |
| Likoff, MJ | 1 |
| McCarthy, D | 1 |
| Shand, DG | 2 |
| Lefkowitz, RJ | 1 |
| Caron, MG | 1 |
| Stiles, GL | 1 |
| Brenner, BM | 1 |
| Duchin, KL | 1 |
| Ichikawa, I | 1 |
| Pfeffer, J | 1 |
| Pfeffer, M | 1 |
| Hoffbrand, BI | 1 |
| Rudolph, W | 2 |
| Dirschinger, J | 2 |
| Goldstein, DS | 1 |
| Beder, SD | 1 |
| Gutgesell, HP | 1 |
| Mullins, CE | 1 |
| McNamara, DG | 1 |
| Silverstein, DK | 1 |
| Karliner, JS | 1 |
| Goldman, L | 1 |
| Furberg, CD | 1 |
| Hawkins, CM | 1 |
| Lichstein, E | 2 |
| Shteĭngardt, IuN | 1 |
| Tiukalova, LI | 1 |
| Markov, VA | 1 |
| Kun, VI | 1 |
| Tsymbaliuk, VP | 1 |
| Pennock, JL | 1 |
| Schneck, DW | 1 |
| Pastelin, G | 1 |
| Mendez, R | 1 |
| Kabela, E | 1 |
| Farah, A | 1 |
| Hill, LM | 1 |
| Breckle, R | 1 |
| Driscoll, DJ | 1 |
| Golikov, AP | 1 |
| Polumiskov, VIu | 1 |
| Berestov, AA | 1 |
| Riabinin, VA | 1 |
| Murakami, E | 1 |
| Takekoshi, N | 1 |
| Matsui, S | 1 |
| Murakami, H | 1 |
| Abrams, J | 1 |
| Thrall, JH | 1 |
| Pitt, B | 1 |
| Brady, TJ | 1 |
| Lessem, J | 1 |
| Tkaczewski, W | 1 |
| Goch, JH | 1 |
| Wichan, P | 1 |
| Kowalski, J | 1 |
| Vedin, A | 1 |
| Wikstrand, J | 1 |
| Wilhelmsson, C | 1 |
| Wallentin, I | 1 |
| Wells, PH | 1 |
| Kaplan, JA | 1 |
| Mukharliamov, NM | 1 |
| Jones, JW | 1 |
| Clark, MA | 1 |
| Mullen, BL | 1 |
| Sanfelippo, JF | 1 |
| Shirey, EK | 1 |
| Proudfit, WL | 1 |
| Hawk, WA | 1 |
| Sakamoto, S | 2 |
| Yasuda, H | 1 |
| Honma, H | 1 |
| Kudo, T | 1 |
| Mikami, T | 1 |
| Mehmel, HC | 1 |
| Stockins, B | 1 |
| Ruffmann, K | 1 |
| Schwarz, F | 1 |
| Kübler, W | 1 |
| Lewis, RP | 1 |
| Boudoulas, H | 1 |
| Leier, CV | 1 |
| Unverferth, DV | 1 |
| Weissler, AM | 1 |
| Gueron, M | 1 |
| Adolph, RJ | 1 |
| Grupp, IL | 1 |
| Gabel, M | 1 |
| Grupp, G | 1 |
| Fowler, NO | 1 |
| Moreyra, AE | 1 |
| Kostis, JB | 1 |
| Amendo, M | 1 |
| Shahar, E | 1 |
| Barzilay, Z | 1 |
| Frand, M | 1 |
| Holubarsch, C | 1 |
| Schneider, R | 1 |
| Pieske, B | 1 |
| Ruf, T | 1 |
| Hasenfuss, G | 1 |
| Fraedrich, G | 1 |
| Posival, H | 1 |
| Just, H | 1 |
| Ko, GT | 1 |
| Chow, CC | 1 |
| Sanderson, JE | 1 |
| Yeung, VT | 1 |
| Cockram, CS | 1 |
| Vaage-Nilsen, M | 1 |
| Hansen, JF | 1 |
| Mellemgaard, K | 1 |
| Hagerup, L | 1 |
| Sigurd, B | 1 |
| Steinmetz, E | 1 |
| Abraham, AS | 1 |
| Balkin, J | 1 |
| Rosenmann, D | 1 |
| Ilan, M | 1 |
| Klutstein, M | 1 |
| Zion, MM | 1 |
| Kamijo, T | 1 |
| Tomaru, T | 1 |
| Miwa, AY | 1 |
| Nakamura, F | 1 |
| Kido, H | 1 |
| Sugimoto, T | 1 |
| Uchida, Y | 1 |
| Wagner, R | 1 |
| von Hundelshausen, B | 1 |
| Tempel, G | 1 |
| Schneck, HJ | 1 |
| Pichlmeier, R | 1 |
| Hipp, R | 1 |
| Haber, HL | 1 |
| Simek, CL | 1 |
| Gimple, LW | 1 |
| Bergin, JD | 1 |
| Subbiah, K | 1 |
| Jayaweera, AR | 1 |
| Powers, ER | 1 |
| Feldman, MD | 1 |
| Levett, JM | 1 |
| Marinelli, CC | 1 |
| Lund, DD | 1 |
| Pardini, BJ | 1 |
| Nader, S | 1 |
| Scott, BD | 1 |
| Augelli, NV | 1 |
| Kerber, RE | 1 |
| Schmid, PG | 1 |
| Shores, J | 1 |
| Berger, KR | 1 |
| Murphy, EA | 1 |
| Pyeritz, RE | 1 |
| Kurose, M | 1 |
| Okamoto, K | 1 |
| Sato, T | 1 |
| Yatsuda, R | 1 |
| Ogata, K | 1 |
| Yasumoto, M | 1 |
| Terasaki, H | 1 |
| Goto, H | 1 |
| Okumura, K | 1 |
| Hayashi, H | 1 |
| Ikeda, J | 1 |
| Kuroda, T | 1 |
| Kubo, K | 1 |
| Sano, T | 1 |
| Suzuki, F | 1 |
| Taylor, BJ | 1 |
| Rogers, BW | 1 |
| Sziszak, TL | 1 |
| Sziszak, TJ | 1 |
| Viscoli, CM | 1 |
| Singer, BH | 1 |
| Rajagopalan, R | 1 |
| Ghate, AV | 1 |
| Subbarayan, P | 1 |
| Linz, W | 1 |
| Schoelkens, BA | 1 |
| Koumi, S | 1 |
| Backer, CL | 1 |
| Arentzen, CE | 1 |
| Sato, R | 1 |
| Newton, GE | 1 |
| Parker, JD | 1 |
| Soltero, ER | 1 |
| Glaeser, DH | 1 |
| Michael, LH | 1 |
| Hartley, CJ | 1 |
| Earle, NR | 1 |
| Li, Z | 1 |
| Lawrie, GM | 1 |
| Cabrera Fischer, EI | 1 |
| Chachques, JC | 1 |
| Christen, AI | 1 |
| Risk, MR | 1 |
| Carpentier, A | 1 |
| Watson, AD | 1 |
| Church, DB | 1 |
| Fischer, MR | 1 |
| Spes, CH | 1 |
| Huss, R | 1 |
| Gärtner, R | 1 |
| Demopoulos, L | 1 |
| Yeh, M | 1 |
| Gentilucci, M | 1 |
| Testa, M | 1 |
| Bijou, R | 1 |
| Katz, SD | 1 |
| Mancini, D | 1 |
| Jones, M | 1 |
| LeJemtel, TH | 2 |
| Aronow, WS | 1 |
| Ahn, C | 1 |
| Kronzon, I | 1 |
| Bartmus, D | 2 |
| Siekmeyer, W | 1 |
| Schulz, R | 1 |
| Bürsch, J | 3 |
| Michel, C | 1 |
| Chati, Z | 1 |
| Mertes, PM | 1 |
| Escanye, JM | 1 |
| Zannad, F | 1 |
| van Veldhuisen, DJ | 1 |
| van Gilst, WH | 1 |
| Francis, GS | 1 |
| Carson, PE | 1 |
| Litwin, SE | 1 |
| Katz, SE | 1 |
| Morgan, JP | 1 |
| Douglas, PS | 1 |
| Mesquita, ET | 2 |
| de Deus, FC | 1 |
| Guedes, CR | 1 |
| Maia, ER | 2 |
| Subieta, CG | 1 |
| Villacorta, H | 2 |
| dos Santos, PA | 1 |
| Cramer, H | 1 |
| dos Santos, VB | 1 |
| Romeo, LJ | 1 |
| Mansuy, P | 1 |
| Mougenot, N | 1 |
| Ramirez-Gil, JF | 1 |
| Bonnefont-Rousselot, D | 1 |
| Raillecove, F | 1 |
| Komajda, M | 2 |
| Lechat, P | 2 |
| Giudice, PL | 1 |
| Gagnol, JP | 1 |
| Bellucci, A | 1 |
| Buffone, G | 1 |
| Careddu, A | 1 |
| Magni, G | 1 |
| Quagliata, T | 1 |
| Pacifici, L | 1 |
| Carminati, P | 1 |
| Metra, M | 1 |
| Nodari, S | 1 |
| Boldi, E | 1 |
| Dei Cas, L | 1 |
| Ng, CY | 1 |
| Ghabrial, H | 1 |
| Morgan, DJ | 1 |
| Ching, MS | 1 |
| Smallwood, RA | 1 |
| Angus, PW | 1 |
| Dash, R | 1 |
| Kadambi, V | 1 |
| Schmidt, AG | 1 |
| Tepe, NM | 1 |
| Biniakiewicz, D | 1 |
| Gerst, MJ | 1 |
| Canning, AM | 1 |
| Abraham, WT | 1 |
| Hoit, BD | 1 |
| Liggett, SB | 1 |
| Lorenz, JN | 1 |
| Kranias, EG | 1 |
| Pogwizd, SM | 1 |
| Schlotthauer, K | 1 |
| Li, L | 1 |
| Yuan, W | 1 |
| Bers, DM | 1 |
| Subietta, CG | 1 |
| Munhoz, C | 1 |
| Romêo Filho, LJ | 1 |
| Hilgers, R | 1 |
| Wessel, A | 2 |
| Werdan, K | 1 |
| Loppnow, H | 1 |
| Doi, M | 1 |
| Yano, M | 1 |
| Kobayashi, S | 1 |
| Kohno, M | 2 |
| Tokuhisa, T | 1 |
| Okuda, S | 1 |
| Suetsugu, M | 1 |
| Hisamatsu, Y | 1 |
| Ohkusa, T | 1 |
| Matsuzaki, M | 1 |
| Shusterman, V | 1 |
| Usiene, I | 1 |
| Harrigal, C | 1 |
| Lee, JS | 1 |
| Kubota, T | 1 |
| London, B | 1 |
| Lee, YC | 1 |
| Gorlin, R | 2 |
| Frishman, W | 1 |
| Silverman, R | 1 |
| Strom, J | 1 |
| Elkayam, U | 1 |
| Sonnenblick, E | 1 |
| Zilcher, H | 1 |
| Glogar, D | 1 |
| Cairns, JA | 1 |
| Nies, AS | 2 |
| Gal, J | 1 |
| Gerber, JG | 1 |
| Mashiro, I | 1 |
| Kinoshita, M | 1 |
| Tomonaga, G | 1 |
| Hoshino, T | 1 |
| Shimono, Y | 1 |
| Plotnick, GD | 1 |
| Greene, HL | 1 |
| Carliner, NH | 1 |
| Becker, LC | 1 |
| Fisher, ML | 1 |
| Alosilla, C | 1 |
| Chadda, KD | 1 |
| Gupta, PK | 1 |
| Tarazi, RC | 1 |
| Bonchek, LI | 1 |
| Olinger, GN | 1 |
| Keelan, MH | 1 |
| Tresch, DD | 1 |
| Siegel, R | 1 |
| Tilley, LP | 1 |
| Weitz, J | 1 |
| Jenkins, WL | 1 |
| Clark, DR | 1 |
| Hamlin, RL | 1 |
| Avery, GJ | 1 |
| Benvenisty, AI | 1 |
| Spotnitz, HM | 1 |
| Glasser, SP | 1 |
| Spoto, E | 1 |
| Solomon, DA | 1 |
| Smith, BF | 1 |
| Carr, ML | 1 |
| Maniscalco, BS | 1 |
| Danilenko, AM | 1 |
| Rodionov, VM | 1 |
| Zakharova, RM | 1 |
| Azevedo A DE, C | 1 |
| Lightner, ES | 1 |
| Allen, HD | 1 |
| Loughlin, G | 1 |
| Ponsonnaille, J | 1 |
| Pailloncy, M | 1 |
| Goujon, B | 1 |
| Marcheix, JC | 1 |
| Gras, H | 1 |
| Kirk, ES | 1 |
| Nelson, GR | 1 |
| Sonnenblick, EH | 2 |
| Mifune, J | 1 |
| Hood, WB | 3 |
| Warren, SG | 1 |
| Brewer, DL | 1 |
| Orgain, ES | 1 |
| Ikram, H | 2 |
| Muiesan, G | 1 |
| Valori, C | 1 |
| Janicki, JS | 1 |
| Dück, K | 1 |
| Strube, G | 1 |
| Knappe, J | 1 |
| Stefan, G | 1 |
| Coodley, EL | 1 |
| Snyder, S | 1 |
| Fiorentini, C | 1 |
| Olivari, MT | 1 |
| Polese, A | 1 |
| Magrini, F | 1 |
| Moruzzi, P | 1 |
| Guazzi, M | 1 |
| Portzer, D | 1 |
| Ostheimer, GW | 1 |
| Alper, MH | 1 |
| Dormois, JC | 1 |
| Young, JL | 1 |
| Alousi, AA | 2 |
| Holland, OB | 1 |
| Kaplan, NM | 1 |
| Warner, AL | 1 |
| Bellah, KL | 1 |
| Raya, TE | 1 |
| Roeske, WR | 1 |
| Goldman, S | 1 |
| Maixent, JM | 1 |
| Berrebi Bertrand, I | 1 |
| Lelièvre, LG | 1 |
| Fénard, S | 1 |
| Qi, WH | 1 |
| Sasaki, F | 1 |
| Ishizaki, T | 1 |
| Takahashi, H | 1 |
| Ameshima, S | 1 |
| Nakai, T | 1 |
| Miyabo, S | 1 |
| Hof, RP | 1 |
| Novosel, D | 1 |
| Evenou, JP | 1 |
| Hof, A | 1 |
| Lopatin, IuM | 1 |
| Ghani, P | 1 |
| Sinitsin, VE | 1 |
| Mareev, VIu | 1 |
| Koiwa, Y | 1 |
| Takagi, T | 1 |
| Kikuchi, J | 1 |
| Honda, H | 1 |
| Hoshi, N | 1 |
| Takishima, T | 1 |
| Forster, C | 1 |
| Wanes, D | 1 |
| Armstrong, PW | 1 |
| Katahira, J | 1 |
| Tanaka, M | 1 |
| Nakao, K | 1 |
| Inukai, T | 1 |
| Millner, RW | 1 |
| Guvendik, L | 1 |
| Clarke, T | 1 |
| Hynd, J | 1 |
| Pepper, JR | 1 |
| Salloum, J | 1 |
| Grosgogeat, Y | 1 |
| Mittmann, C | 1 |
| Schwinger, RH | 1 |
| Erdmann, E | 1 |
| Leirner, AA | 1 |
| Marques, E | 1 |
| Ribeiro, MP | 1 |
| Lage, SG | 1 |
| Jatene, AD | 1 |
| Chizh, VD | 1 |
| Stone, CK | 4 |
| Imai, N | 4 |
| Sladek, CD | 2 |
| Liang, CS | 4 |
| Sinitsyn, SP | 1 |
| Maruyama, M | 1 |
| Kamiya, J | 1 |
| Kaiho, T | 1 |
| Kobari, T | 1 |
| Callens-el Amrani, F | 1 |
| Paolaggi, F | 1 |
| Swynghedauw, B | 1 |
| Brodde, OE | 1 |
| Zerkowski, HR | 1 |
| Borst, HG | 1 |
| Maier, W | 1 |
| Michel, MC | 1 |
| Ogawa, T | 1 |
| Hieda, N | 1 |
| Sugiyama, S | 1 |
| Ito, T | 1 |
| Satake, T | 1 |
| Ozawa, T | 1 |
| Golf, S | 1 |
| Jahnsen, T | 1 |
| Simonsen, S | 1 |
| Attramadal, A | 1 |
| Hansson, V | 1 |
| Moncloa, F | 1 |
| Sromovsky, JA | 1 |
| Walker, JF | 1 |
| Davies, RO | 1 |
| Frishman, WH | 1 |
| Ruggio, J | 1 |
| Furberg, C | 1 |
| Ruffolo, RR | 1 |
| Kopia, GA | 1 |
| Giudicelli, JF | 1 |
| Kassis, E | 1 |
| Jacobsen, TN | 1 |
| Mogensen, F | 1 |
| Amtorp, O | 1 |
| Woolf, PD | 1 |
| Kawashima, S | 1 |
| Tuttle, RR | 1 |
| Reikerås, O | 1 |
| Gunnes, P | 1 |
| Sørlie, D | 1 |
| Ekroth, R | 1 |
| Mjøs, OD | 1 |
| Hayes, JS | 1 |
| Narimatsu, A | 1 |
| Kitada, Y | 1 |
| Satoh, N | 1 |
| Suzuki, R | 1 |
| Okushima, H | 1 |
| Desai, SP | 1 |
| Pierce, EC | 1 |
| Fleming, TC | 1 |
| Muir, WW | 1 |
| McGuirk, SM | 1 |
| Bergmans, MG | 1 |
| Jonker, GJ | 1 |
| Kock, HC | 1 |
| Schroeder, JS | 1 |
| Carter, RS | 1 |
| Snyder, JV | 1 |
| Pinsky, MR | 2 |
| Chadda, K | 1 |
| Goldstein, S | 1 |
| Byington, R | 1 |
| Curb, JD | 1 |
| Matuschak, GM | 1 |
| Klain, M | 1 |
| Strauss, WE | 1 |
| Egan, T | 1 |
| McIntyre, KM | 1 |
| Parisi, AF | 1 |
| Canter, JM | 1 |
| Fort, DJ | 1 |
| Doshchitsin, VL | 1 |
| Simonov, VI | 1 |
| Basta, LL | 1 |
| Takeshita, A | 1 |
| Theilen, EO | 1 |
| Ehrenhaft, JL | 1 |
| Ehlers, KH | 1 |
| Tajik, AJ | 1 |
| Giuliani, ER | 1 |
| Weidman, WH | 1 |
| Brandenburg, RO | 1 |
| McGoon, DC | 1 |
| Armstrong, BK | 1 |
| Beahan, PG | 1 |
| Leedman, RL | 1 |
| Goodwin, JF | 6 |
| Webb-Peplos, MM | 1 |
| Croxson, RS | 1 |
| Khanna, P | 1 |
| Raphael, MJ | 1 |
| Steiner, RE | 1 |
| Oakley, CM | 3 |
| Singh, BN | 1 |
| Bernauer, W | 1 |
| Schanz, HM | 1 |
| Greenblatt, DJ | 1 |
| Koch-Weser, J | 2 |
| Simpson, FO | 1 |
| Shah, PM | 1 |
| Adelman, AG | 2 |
| Wigle, ED | 2 |
| Gobel, FL | 1 |
| Burchell, HB | 1 |
| Hardarson, T | 1 |
| Curiel, R | 1 |
| De La Calzada, C | 1 |
| Zelis, R | 1 |
| Mason, DT | 1 |
| Amsterdam, EA | 2 |
| Green, JF | 1 |
| Clausen, J | 1 |
| Felsby, M | 1 |
| Jorgensen, FS | 1 |
| Nielsen, BL | 1 |
| Roin, J | 1 |
| Strange, B | 1 |
| Taylor, JA | 1 |
| Stutz, DR | 1 |
| Brogan, E | 1 |
| Morand, P | 1 |
| Lafranchi, J | 1 |
| Raffoux, P | 1 |
| Vatner, SF | 1 |
| Higgins, CB | 1 |
| Khalfen, ESh | 1 |
| Sorokina, VS | 1 |
| Iaikova, MM | 1 |
| Stephen, SA | 2 |
| Vogel, JH | 1 |
| Chidsey, CA | 1 |
| Layton, C | 1 |
| Di Nunzio, H | 1 |
| Gent, G | 1 |
| Freedman, P | 1 |
| McDonald, A | 1 |
| Sakai, K | 1 |
| Sugano, S | 1 |
| Isono, C | 1 |
| Katz, AM | 1 |
| Russek, HI | 1 |
| Doherty, JE | 1 |
| Kane, JJ | 1 |
| Bourel, M | 1 |
| Gouffault, J | 1 |
| Lenoir, P | 1 |
| Guillou, M | 1 |
| Simon, M | 1 |
| Murie, N | 1 |
| Epstein, SE | 1 |
| Skelton, CL | 1 |
| Levey, GS | 1 |
| Entman, M | 1 |
| Andersen, HT | 1 |
| Witty, RT | 1 |
| Davis, JO | 1 |
| Shade, RE | 1 |
| Johnson, JA | 1 |
| Prewitt, RL | 1 |
| Lydtin, H | 1 |
| Froer, KL | 1 |
| König, E | 1 |
| Grünberg, G | 1 |
| Miquel, C | 1 |
| Del Rio, R | 1 |
| Pliscoff, S | 1 |
| Majid, PA | 1 |
| Saxton, C | 1 |
| Dykes, JR | 1 |
| Galvin, MC | 1 |
| Taylor, SH | 1 |
| Horowitz, W | 1 |
| Canary, JJ | 1 |
| Ashton, F | 1 |
| Barrett, AM | 1 |
| Nunn, B | 1 |
| Koji, T | 1 |
| Chung, EK | 1 |
| Solti, F | 1 |
| Szabó, Z | 1 |
| Rényi-Vámos, F | 1 |
| Kárai, K | 1 |
| Bodor, E | 1 |
| Ambrosioni, E | 1 |
| Bracchetti, D | 1 |
| Russo, F | 1 |
| Catizone, L | 1 |
| Perri, G | 1 |
| Magnani, B | 1 |
| Lubbers, WJ | 1 |
| Losekoot, TG | 1 |
| Anderson, RH | 1 |
| Wellens, HJ | 1 |
| Aroesty, JM | 1 |
| Cohen, SI | 1 |
| Morkin, E | 1 |
| Dalen, JE | 1 |
| Alpert, JS | 1 |
| Cohn, LH | 1 |
| Black, H | 1 |
| Collins, JJ | 1 |
| Kones, RJ | 1 |
| Phillips, JH | 1 |
| Hersh, J | 1 |
| Hansson, L | 1 |
| Malmcrona, R | 1 |
| Olander, R | 1 |
| Rosenhall, L | 1 |
| Westerlund, A | 1 |
| Aberg, H | 1 |
| Hood, B | 1 |
| Maillé, JG | 1 |
| Dyrda, I | 1 |
| Paiement, B | 1 |
| Boulanger, M | 1 |
| Lefemine, AA | 1 |
| Flessas, A | 1 |
| Moon, HS | 1 |
| Strauer, BE | 1 |
| Zoneraich, S | 1 |
| Zoneraich, O | 1 |
| Viles, PH | 1 |
| Manning, JA | 1 |
| Fernandes, M | 1 |
| Kim, KE | 1 |
| Moyer, JH | 1 |
| Rowe, GG | 1 |
| Abel, FL | 1 |
| Sutherland, AE | 1 |
| Haselby, K | 1 |
| Bădărău, G | 1 |
| Coşovanu, A | 1 |
| Levy, RH | 1 |
| Smith, GH | 1 |
| Levitsky, S | 1 |
| Schuette, WH | 1 |
| Kempner, KM | 1 |
| Sloane, R | 1 |
| Souther, SG | 1 |
| Mullin, EM | 1 |
| Morrow, AG | 1 |
| Maron, BJ | 1 |
| Bell, BB | 1 |
| Mirowski, M | 1 |
| Biró, L | 1 |
| Szebeni, A | 1 |
| Csàszàr, G | 1 |
| Forker, AD | 1 |
| Wilson, CS | 1 |
| Alekseev, GK | 1 |
| Martynov, IV | 1 |
| Tikhonov, AA | 1 |
| Zhibkov, IuE | 1 |
| Bakulin, VD | 1 |
| Felderhof, CH | 1 |
| Gebhardt, W | 2 |
| König, K | 1 |
| Büchner, C | 1 |
| Gault, JE | 1 |
| Wolfson, S | 1 |
| Patton, RD | 1 |
| Tsagaris, TJ | 1 |
| Sutton, RB | 1 |
| Kuida, H | 1 |
| Nager, F | 1 |
| Arora, RB | 1 |
| Bagchi, N | 1 |
| Gupta, OP | 1 |
| Hopkins, SJ | 1 |
| Cohen, HE | 1 |
| Meltzer, LE | 1 |
| Lattimer, G | 1 |
| Linares, H | 1 |
| Agrin, R | 1 |
| Lindsay, AE | 1 |
| Nelson, RM | 1 |
| Abildskov, JA | 1 |
| Wyatt, R | 1 |
| Attar, S | 1 |
| Fardin, R | 1 |
| Ayella, R | 1 |
| McLaughlin, JS | 1 |
| Frisch, P | 1 |
| Feola, M | 1 |
| Haiderer, O | 1 |
| Kennedy, JH | 1 |
| Bajusz, E | 1 |
| Homburger, F | 1 |
| Baker, JR | 1 |
| Bogdonoff, P | 1 |
| Nestel, PJ | 1 |
| Adamska-Dyniewska, H | 1 |
| Fidelle, J | 1 |
| Cloup, M | 1 |
| Nouaille, J | 1 |
| Varghese, PJ | 1 |
| Allen, JR | 1 |
| Rosenquist, GC | 1 |
| Rowe, RD | 1 |
| Miasnikov, LA | 1 |
| Krasnikov, IuA | 1 |
| Nikolaeva, EN | 1 |
| Grigor'iants, RA | 1 |
| Lujf, A | 1 |
| Mose, K | 1 |
| Schwarzmeier, J | 1 |
| Grandjean, T | 1 |
| Rivier, JL | 1 |
| Conway, N | 1 |
| Seymour, J | 1 |
| Gelson, A | 1 |
| Hamer, J | 1 |
| Glick, G | 1 |
| Parmley, WW | 1 |
| Wechsler, AS | 1 |
| Norris, RM | 1 |
| Bensley, KE | 1 |
| Caughey, DE | 1 |
| Scott, PJ | 1 |
| Blümchen, G | 1 |
| Cobb, FR | 1 |
| Blumenschein, SD | 1 |
| Sealy, WC | 1 |
| Boineau, JP | 1 |
| Wagner, GS | 1 |
| Wallace, AG | 1 |
| Krayenbühl, HP | 1 |
| Bussmann, WD | 1 |
| Turina, M | 1 |
| Lüthy, E | 1 |
| Lega, P | 1 |
| Milazzotto, F | 1 |
| Ito, Y | 1 |
| Kelly, DT | 1 |
| Kissling, G | 1 |
| Segarra-Domenech, J | 1 |
| Jacob, R | 1 |
| Lamont, NM | 1 |
| Posel, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| "'' Efficacy of Propranolol in the Treatment of Infantile Hemangioma"[NCT04684667] | Phase 2 | 100 participants (Anticipated) | Interventional | 2021-01-01 | Not yet recruiting | ||
| Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy[NCT04133532] | Phase 4 | 22 participants (Actual) | Interventional | 2020-03-05 | Completed | ||
| The Effect of Preoperative Exercise on Postoperative Outcome in AAA Patients: Pilot Study[NCT02845167] | 21 participants (Actual) | Interventional | 2011-09-30 | Completed | |||
| [NCT00000492] | Phase 3 | 0 participants | Interventional | 1977-09-30 | Completed | ||
| PRospectIve Study of Sacubitril/ValsarTan on MyocardIal OxygenatioN and Fibrosis in PatiEnts With Heart Failure and Preserved Ejection Fraction[NCT04128891] | Phase 3 | 0 participants (Actual) | Interventional | 2020-02-01 | Withdrawn (stopped due to Funding not approved) | ||
| Identification of Echocardiographic Criteria Predictive of the Inefficacy and/or the Unsafeness of Recruitment Maneuvers in Patients Suffering From Acute Respiratory Distress Syndrome[NCT01768949] | 30 participants (Actual) | Interventional | 2013-02-28 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
51 reviews available for propranolol and Cardiac Failure
| Article | Year |
|---|---|
Diverse pharmacological properties, trial results, comorbidity prescribing and neural pathophysiology suggest European hypertension guideline downgrading of beta-blockers is not justified.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Cardiovascular Diseases; Comorbidity | 2022 |
Beta-blockers for congestive heart failure in children.
Topics: Adolescent; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Child; Child, Preschool; Heart Fail | 2020 |
Beta-blockers for congestive heart failure in children.
Topics: Adolescent; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Child; Child, Preschool; Heart Fail | 2016 |
Infantile haemangioma.
Topics: Adrenergic beta-Antagonists; Heart Failure; Hemangioma; Humans; Infant; Propranolol; Respiratory Dis | 2017 |
Multifocal infantile hepatic hemangiomas--imaging strategy and response to treatment after propranolol and steroids including review of the literature.
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Female; Glucocorticoids; Heart Failure; Hema | 2012 |
Should beta-blockers be used for the treatment of pediatric patients with chronic heart failure?
Topics: Adolescent; Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Child; Child, Preschool; Chronic Di | 2002 |
The beta-adrenergic receptors.
Topics: Adrenergic beta-Antagonists; Animals; Animals, Newborn; Arrhythmias, Cardiac; Autoantibodies; Calciu | 2002 |
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Ca | 1981 |
Mechanisms of membrane-receptor regulation. Biochemical, physiological, and clinical insights derived from studies of the adrenergic receptors.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Affinity Labels; Animals; Asthma; Catecholamines; Coron | 1984 |
Perioperative cardiac cure.
Topics: Arrhythmias, Cardiac; Coronary Disease; Digitalis Glycosides; Electrocardiography; Heart Diseases; H | 1983 |
Cardiac risks and complications of noncardiac surgery.
Topics: Adult; Aged; Anesthesia; Anti-Bacterial Agents; Coronary Disease; Heart Diseases; Heart Failure; Hem | 1983 |
Perioperative management of drug therapy.
Topics: Anti-Arrhythmia Agents; Anticoagulants; Antihypertensive Agents; Cardiac Glycosides; Diuretics; Hear | 1983 |
Nitrate tolerance and dependence.
Topics: Ambulatory Care; Angina Pectoris; Animals; Cardiovascular Diseases; Dogs; Drug Tolerance; Heart Fail | 1980 |
Radionuclide wall motion study and ejection fraction in clinical practice.
Topics: Aminophylline; Coronary Artery Bypass; Coronary Disease; Doxorubicin; Erythrocytes; Heart; Heart Dis | 1980 |
Optimal management of patients with ischemic heart disease for noncardiac surgery by complementary anesthesiologist and cardiologist interaction.
Topics: Aged; Anesthesia; Anesthesiology; Arrhythmias, Cardiac; Cardiology; Cerebrovascular Disorders; Coron | 1981 |
[Heart failure: achievements and prospects].
Topics: Digoxin; Echocardiography; Electrocardiography; Heart Failure; Humans; Plethysmography, Impedance; P | 1982 |
Beta-blocker therapy in heart failure: pathophysiology and clinical results.
Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Exe | 1999 |
Myocardial infarction size: measurement and modification.
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Coronary Disease; Creatine Kinase; Digitalis Glycoside | 1977 |
Beta-adrenergic blockade in some cardiovascular diseases.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Arrhythmias, Cardiac; Cardiovascular Diseases; Heart F | 1975 |
Pharmacologic and other forms of medical therapy in feline cardiac disease.
Topics: Animals; Cardiomyopathies; Cat Diseases; Cats; Diet, Sodium-Restricted; Digoxin; Electrocardiography | 1977 |
A review of drugs affecting the heart.
Topics: Anesthetics; Animals; Arrhythmias, Cardiac; Calcium; Catecholamines; Cats; Digitalis Glycosides; Diu | 1977 |
Modification of infarct size.
Topics: Animals; Assisted Circulation; Coronary Circulation; Creatine Kinase; Electrocardiography; Heart; He | 1975 |
[Beta-blockers in the treatment of heart failure].
Topics: Adrenergic beta-Antagonists; Drug Therapy, Combination; Heart Failure; Humans; Metoprolol; Propranol | 1990 |
Enalapril in hypertension and congestive heart failure. Overall review of efficacy and safety.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Blood Pressure; Enalapril; Female | 1985 |
Use of beta-adrenergic blocking agents after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Heart Failure; Humans; M | 1985 |
Importance of receptor regulation in the pathophysiology and therapy of congestive heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Disease Models, Animal; Dobutamine; Dogs; | 1986 |
Fetal supraventricular tachycardia. Review of the literature.
Topics: Adult; Cesarean Section; Digitalis; Drug Therapy, Combination; Electric Countershock; Electrocardiog | 1985 |
Combination therapy with isosorbide dinitrate: current status and the future.
Topics: Angina Pectoris; Coronary Vasospasm; Diltiazem; Drug Therapy, Combination; Esophageal Achalasia; Exe | 1985 |
Supraventricular and ventricular dysrhythmias in infants and children.
Topics: Arrhythmias, Cardiac; Bradycardia; Cardiac Complexes, Premature; Child; Child, Preschool; Deafness; | 1972 |
Treatment of the cardiomyopathies.
Topics: Adrenergic beta-Antagonists; Alcoholism; Angina Pectoris; Anticoagulants; Atrial Fibrillation; Blood | 1973 |
Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program.
Topics: Adrenergic beta-Antagonists; Bradycardia; Central Nervous System; Depression; Heart; Heart Failure; | 1974 |
Beta-adrenergic receptor blocking drugs in hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Antidepressive Agents; Antihy | 1974 |
The cardiomyopathies.
Topics: Adrenergic beta-Antagonists; Adult; Amyloidosis; Angiography; Cardiac Output; Cardiomyopathies; Cate | 1974 |
Current concepts in the drug management of angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Coronary Circulation; Diagnosis, Differential; Digital | 1974 |
Biochemical "defect" in the hypertrophied and failing heart: deleterious or compensatory?
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Calcium; Cardiomegaly; Coronary Disease; | 1973 |
Clinical pharmacology and therapeutics use of digitalis glycosides.
Topics: Adenosine Triphosphatases; Arrhythmias, Cardiac; Digitalis Glycosides; Digitoxin; Digoxin; Heart; He | 1973 |
Adenyl cyclase and myocardial contractility.
Topics: Adenine Nucleotides; Adenylyl Cyclases; Animals; Catecholamines; Cats; Cyclic AMP; Enzymes; Epinephr | 1970 |
[Glucagon--a therapeutic alternative in heart failure?].
Topics: Adenylyl Cyclases; Animals; Blood Circulation; Cyclic AMP; Dogs; Glucagon; Heart; Heart Failure; Hum | 1971 |
[Beta-receptor-blocking agents and anesthesia].
Topics: Adrenal Gland Neoplasms; Anesthesia; Angina Pectoris; Arrhythmias, Cardiac; Asthma; Cardiomyopathy, | 1969 |
Control of myocardial oxygen consumption: physiologic and clinical considerations.
Topics: Adenosine Triphosphate; Adrenergic beta-Antagonists; Angina Pectoris; Animals; Blood Pressure; Calci | 1971 |
Digitalis intoxication.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Digitalis Glycosides; Edetic Acid; Electric Count | 1972 |
The cardiomyopathies.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Anticoagulants; Atrial Fibrillation; Cardiomegaly; Car | 1972 |
Patients with cardiac valve prosthesis: subsequent anaesthetic management for non-cardiac surgical procedures.
Topics: Anemia, Hemolytic; Anesthesia, General; Anesthetics; Anti-Bacterial Agents; Anticoagulants; Arrhythm | 1973 |
[Criteria for the evaluation of myocardial contractility of the hypertrophied and insufficient heart. II].
Topics: Action Potentials; Animals; Aortic Valve Insufficiency; Blood Pressure; Cardiac Catheterization; Car | 1973 |
Life-threatening arrhythmias.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Bradycardia; Electrocardiography; Female; Heart | 1973 |
Correlation of pathophysiology and pharmacotherapy in primary hypertension.
Topics: Blood Pressure; Cardiac Output; Cardiac Volume; Diuretics; Furosemide; Guanethidine; Heart Failure; | 1973 |
Recent advances in the treatment of congenital heart disease.
Topics: Age Factors; Arrhythmias, Cardiac; Child; Child, Preschool; Chlorothiazide; Diet, Sodium-Restricted; | 1974 |
Hypertensive emergencies.
Topics: Acute Kidney Injury; Adrenal Gland Neoplasms; Antihypertensive Agents; Aortic Aneurysm; Blood Volume | 1974 |
Responses of the coronary circulation to physiologic changes and pharmacologic agents.
Topics: Angina Pectoris; Animals; Atropine; Blood Pressure; Cardiac Output; Coronary Circulation; Dogs; Epin | 1974 |
Propranolol.
Topics: Administration, Oral; Angina Pectoris; Arrhythmias, Cardiac; Asthma; Blood Pressure; Cardiac Output; | 1974 |
Management of arrhythmias in acute myocardial infarction.
Topics: Acid-Base Equilibrium; Adams-Stokes Syndrome; Arrhythmias, Cardiac; Atropine; Bradycardia; Cardiac O | 1971 |
32 trials available for propranolol and Cardiac Failure
| Article | Year |
|---|---|
Heart rate variability in infants with heart failure due to congenital heart disease: reversal of depressed heart rate variability by propranolol.
Topics: Adult; Anti-Arrhythmia Agents; Digoxin; Heart Defects, Congenital; Heart Failure; Heart Rate; Hemody | 2002 |
Effects of propranolol on recovery of heart rate variability following acute myocardial infarction and relation to outcome in the Beta-Blocker Heart Attack Trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Autonomic Nervous System; Death, Sudden, Cardiac; Female; | 2003 |
Effects of therapeutic beta blockade on myocardial function and cardiac remodelling in congenital cardiac disease.
Topics: Adrenergic beta-Antagonists; Digoxin; Diuretics; Dose-Response Relationship, Drug; Drug Administrati | 2003 |
[Contribution of antioxidant properties of carvedilol in its effect on cardiac remodeling in patients with ischemic heart disease with incipient heart failure].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Antioxida | 2003 |
Established beta-adrenergic receptor blocking therapy and acute myocardial infarction. A clinical study of risks and benefits.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Femal | 1980 |
A randomized trial of propranolol in patients with acute myocardial infarction. II. Morbidity results.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Fo | 1983 |
Effect of propranolol in postinfarction patients with mechanical or electrical complications.
Topics: Arrhythmias, Cardiac; Clinical Trials as Topic; Double-Blind Method; Follow-Up Studies; Heart Failur | 1984 |
Radionuclide evaluation of CHF.
Topics: Adolescent; Adult; Coronary Disease; Digoxin; Female; Heart Aneurysm; Heart Failure; Hemodynamics; H | 1981 |
[Ergometric test in sympatheticotonia after administration of propranolol, pindolol, verapamil and oxazepam].
Topics: Adolescent; Adrenergic Fibers; Adult; Clinical Trials as Topic; Exercise Test; Heart; Heart Failure; | 1980 |
Left ventricular function and beta-blockade in chronic ischaemic heart failure. Double-blind, cross-over study of propranolol and penbutolol using non-invasive techniques.
Topics: Clinical Trials as Topic; Coronary Disease; Digoxin; Double-Blind Method; Heart Failure; Heart Ventr | 1980 |
Effect of verapamil on the prognosis of patients with early postinfarction electrical or mechanical complications. The Danish Verapamil Infarction Trial II (DAVIT II).
Topics: Aged; Arrhythmias, Cardiac; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; M | 1995 |
Long-term follow-up after acute myocardial infarction in patients randomized to treatment with intravenous magnesium or intravenous propranolol in the acute phase.
Topics: Aged; Female; Follow-Up Studies; Heart Failure; Humans; Infusions, Intravenous; Magnesium Sulfate; M | 1994 |
Why do patients with congestive heart failure tolerate the initiation of beta-blocker therapy?
Topics: Adrenergic beta-Antagonists; Depression, Chemical; Female; Heart Failure; Hemodynamics; Humans; Male | 1993 |
Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome.
Topics: Adolescent; Adult; Aorta; Aortic Aneurysm; Aortic Dissection; Aortic Valve Insufficiency; Dilatation | 1994 |
Beta-blockers after myocardial infarction: influence of first-year clinical course on long-term effectiveness.
Topics: Adult; Aged; Arrhythmias, Cardiac; Bias; Comorbidity; Double-Blind Method; Female; Follow-Up Studies | 1993 |
Nonselective beta-adrenergic blockade with carvedilol does not hinder the benefits of exercise training in patients with congestive heart failure.
Topics: Adaptation, Physiological; Adrenergic beta-Antagonists; Aerobiosis; Aged; Angiotensin-Converting Enz | 1997 |
Effect of propranolol versus no propranolol on total mortality plus nonfatal myocardial infarction in older patients with prior myocardial infarction, congestive heart failure, and left ventricular ejection fraction > or = 40% treated with diuretics plus
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Diur | 1997 |
Use of propranolol in heart failure patients: safety, tolerability, and effects on left ventricular function.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Electrocardiography; Female; Heart Failure; Humans; Male; | 2001 |
Propranolol treatment of congestive heart failure in infants with congenital heart disease: The CHF-PRO-INFANT Trial. Congestive heart failure in infants treated with propanol.
Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Digoxin; Diuretics; Heart Defects, Congenital; Hear | 2001 |
Beta-receptor downregulation in congenital heart disease: a risk factor for complications after surgical repair?
Topics: Biopsy; Child, Preschool; Digoxin; Diuretics; Down-Regulation; Drug Therapy, Combination; Female; He | 2002 |
[Echocardiographic evaluation of left ventricular function during therapy with cardiovascularly effective drugs].
Topics: Digoxin; Echocardiography; Heart; Heart Failure; Heart Ventricles; Humans; Isoproterenol; Propranolo | 1976 |
[Potential possibilities of using adrenergic beta blockers in chronic heart failure].
Topics: Adolescent; Adult; Aged; Chronic Disease; Female; Heart Failure; Hemodynamics; Humans; Male; Metopro | 1992 |
Use of beta-adrenergic blocking agents after myocardial infarction.
Topics: Adrenergic beta-Antagonists; Clinical Trials as Topic; Double-Blind Method; Heart Failure; Humans; M | 1985 |
Effect of propranolol after acute myocardial infarction in patients with congestive heart failure.
Topics: Heart Failure; Humans; Myocardial Infarction; Propranolol; Retrospective Studies; Time Factors | 1986 |
Absence of prophylactic effect of propranolol in myocardial infarction.
Topics: Arrhythmias, Cardiac; Aspartate Aminotransferases; Coronary Disease; Electrocardiography; Female; He | 1966 |
Propranolol in acute myocardial infarction. A multicentre trial.
Topics: Adult; Aged; Clinical Trials as Topic; Female; Heart Arrest; Heart Failure; Humans; Hypotension; Mal | 1966 |
[Load insufficiency of the heart due to beta receptor blocking agents].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Blood Pressure; Digitalis Glycosides; Ele | 1969 |
Propranolol in hypertension. Report on 158 patients treated up to one year.
Topics: Adult; Aged; Airway Obstruction; Blood Pressure; Bradycardia; Clinical Trials as Topic; Creatinine; | 1972 |
Cardiovascular effects of beta blockade with inderal in normal subjects.
Topics: Blood Pressure; Blood Volume; Cardiac Output; Cardiac Volume; Cardiovascular System; Clinical Trials | 1968 |
Dyspnoea and angina: a clinical study.
Topics: Amino Alcohols; Angina Pectoris; Clinical Trials as Topic; Dyspnea; Female; Heart Failure; Heart Ven | 1969 |
Evaluation of long-term use of propranolol in angina pectoris.
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Female; Heart Failure; Humans; Male; Mi | 1969 |
Evaluation of propranolol ("Inderal") in the treatment of angina pectoris.
Topics: Adult; Angina Pectoris; Asthma; Clinical Trials as Topic; Female; Heart Failure; Humans; Male; Middl | 1966 |
240 other studies available for propranolol and Cardiac Failure
| Article | Year |
|---|---|
Clinical evaluation of transcatheter arterial embolization combined with propranolol orally treatment of infantile hepatic hemangioma.
Topics: Child; Embolization, Therapeutic; Female; Heart Failure; Hemangioma; Hemangioma, Capillary; Humans; | 2022 |
Coexistence of Graves' disease with acute rheumatic fever treated as thyroid storm in young Thai patient.
Topics: Child; Chorea; Female; Graves Disease; Heart Failure; Humans; Propranolol; Rheumatic Fever; Southeas | 2023 |
A Case of Consumptive Hypothyroidism in a 1-Month-Old Boy with Diffuse Infantile Hepatic Hemangiomas.
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents; Cholestasis; Drug Therapy, Combination; Heart | 2020 |
Infantile hepatic hemangioendothelioma associated with pulmonary artery hypertension and cardiac insufficiency successfully treated with transcatheter arterial embolization and propranolol: A case report.
Topics: Antihypertensive Agents; Catheterization; Combined Modality Therapy; Embolization, Therapeutic; Hear | 2020 |
β-Blocker Use and Risk of Mortality in Heart Failure Patients Initiating Maintenance Dialysis.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Atenolol; Bisoprolol; Carvedilol; Cause of Dea | 2021 |
β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies.
Topics: Adrenergic beta-Antagonists; Age Factors; Arrhythmias, Cardiac; Atenolol; Body Mass Index; Californi | 2017 |
The neuropeptide galanin promotes an anti-thrombotic phenotype on endocardial endothelial cells from heart failure patients.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Aged; Antithrombins; Carbazoles; Carve | 2017 |
Propranolol for gastrointestinal bleeding in two patients with continuous flow left ventricle assist device.
Topics: Anemia; Female; Gastrointestinal Hemorrhage; Heart Failure; Heart-Assist Devices; Humans; Male; Midd | 2018 |
A quantitative analysis of the spontaneous reporting of congestive heart failure-related adverse events with systemic anti-fungal drugs.
Topics: Adverse Drug Reaction Reporting Systems; Amphotericin B; Antifungal Agents; Databases, Factual; Drug | 2013 |
Gβγ-independent recruitment of G-protein coupled receptor kinase 2 drives tumor necrosis factor α-induced cardiac β-adrenergic receptor dysfunction.
Topics: Adrenergic beta-Antagonists; Animals; Disease Models, Animal; G-Protein-Coupled Receptor Kinase 2; H | 2013 |
[Obstructive respiratory tract diseases: contraindications to beta blockers crumble].
Topics: Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Antagonists; Asthma; Comorbidit | 2014 |
[Heart failure as early manifestation of neonatal hyperthyroidism. Case report].
Topics: Adrenergic beta-Antagonists; Antithyroid Agents; Fetal Growth Retardation; Heart Failure; Humans; Hy | 2014 |
An unexpected cause of infantile dyspnea.
Topics: Cough; Dyspnea; Electrocardiography; Emergency Service, Hospital; Follow-Up Studies; Heart Failure; | 2017 |
ECGs in the ED.
Topics: Arrhythmias, Cardiac; Atrioventricular Node; Catheter Ablation; Child; Combined Modality Therapy; Co | 2008 |
Heart rate variability in rats with experimental chronic heart failure and long-term exposure to beta-adrenoblockers.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Benzopyrans; Bisoprolol; Ethanolamines; Heart Failur | 2009 |
Levosimendan as a rescue drug in experimental propranolol-induced myocardial depression: a randomized study.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Dobutamine; Double-Blind Method; Drug Over | 2009 |
Amelioration of cardiac remodeling in congestive heart failure by beta-adrenoceptor blockade is associated with depression in sympathetic activity.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blood Pressure; Depression, Chemical; Electrocardiog | 2010 |
β-adrenergic blockade attenuates cardiac dysfunction and myofibrillar remodelling in congestive heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Blotting, Northern; Ca(2+) Mg(2+)-ATPase; Dose-Respo | 2011 |
In response to Leppikangas H, et al, Levosimendan as a rescue drug in experimental propranolol-induced myocardial depression: a randomized study.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Heart Failure; Hemodynamics; Hydrazones; P | 2010 |
Chylous ascites as a manifestation of thyrotoxic cardiomyopathy in a patient with untreated Graves' disease.
Topics: Cardiomyopathies; Chylous Ascites; Diuretics; Female; Graves Disease; Heart Failure; Humans; Propran | 2010 |
Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis.
Topics: Adrenal Cortex Hormones; Female; Heart Failure; Hemangioma; Humans; Infant; Liver Neoplasms; Male; P | 2010 |
Replacement of carvedilol for propranolol in patients with heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Carbazoles; Carvedilol; Drug Substitution; Echocardiography; Fol | 2010 |
Loss of PI3Kγ enhances cAMP-dependent MMP remodeling of the myocardial N-cadherin adhesion complexes and extracellular matrix in response to early biomechanical stress.
Topics: Adrenergic beta-Antagonists; Animals; Antigens, CD; beta Catenin; Biomechanical Phenomena; Cadherins | 2010 |
Influence of rotary blood pumps over preload recruitable stroke work.
Topics: Animals; Anti-Arrhythmia Agents; Equipment Design; Female; Goats; Heart; Heart Failure; Heart Rate; | 2010 |
Heart failure: acute ischemic events in HF--should we include sudden death?
Topics: Adrenergic beta-1 Receptor Antagonists; Antihypertensive Agents; Benzopyrans; Death, Sudden, Cardiac | 2011 |
Cytoskeletal role in protection of the failing heart by β-adrenergic blockade.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Adrenergic beta-Agon | 2012 |
Hepatocellular necrosis, fibrosis and microsomal activity determine the hepatic pharmacokinetics of basic drugs in right-heart-failure-induced liver damage.
Topics: Adrenergic Antagonists; Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti | 2012 |
Graves' disease--familiar foe, unfamiliar face.
Topics: Adult; Anti-Arrhythmia Agents; Antihypertensive Agents; Antithyroid Agents; Atrial Fibrillation; Car | 2012 |
Preservation of the baroreceptor heart rate reflex by chemical sympathectomy in experimental heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Baroreflex; Blood Pressure; Body Weight; Bradycardia; Catechol | 2002 |
Prenatal diagnosis and treatment of fetal long QT syndrome: a case report.
Topics: Adult; Bradycardia; Bundle-Branch Block; Electrocardiography; Female; Fetal Diseases; Heart Block; H | 2002 |
Calcium dynamics in the failing heart: restoration by beta-adrenergic receptor blockade.
Topics: Adrenergic beta-Antagonists; Aniline Compounds; Animals; Blotting, Western; Calcium; Calcium Signali | 2003 |
Hidden hyperthyroidism in a young male patient.
Topics: Adult; Antithyroid Agents; Carbimazole; Echocardiography; Heart Failure; Humans; Hyperthyroidism; Ma | 2003 |
Partial agonist activity of bucindolol is dependent on the activation state of the human beta1-adrenergic receptor.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; | 2003 |
PROPRANOLOL (INDERAL) IN PERSISTENT VENTRICULAR FIBRILLATION.
Topics: Digitalis Glycosides; Drug Therapy; Electric Countershock; Heart Arrest; Heart Failure; Heart Massag | 1965 |
Circadian and short-term regulation of blood pressure and heart rate in transgenic mice with cardiac overexpression of the beta1-adrenoceptor.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Circadian Rhythm; Heart; Heart Failure; Heart | 2004 |
Suppression by propranolol and amiodarone of an electrical storm refractory to metoprolol and amiodarone.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Defibrillator | 2005 |
Alterations of alpha-adrenergic modulations of coronary microvascular tone in dogs with heart failure.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood | 2005 |
Carvedilol blocks beta2- more than beta1-adrenoceptors in human heart.
Topics: Adrenergic beta-Antagonists; Calcium Channels, L-Type; Carbazoles; Carvedilol; Dose-Response Relatio | 2006 |
Survival benefits of different antiadrenergic interventions in pressure overload left ventricular hypertrophy/failure.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Aorta, Abdominal; Blood Pressure | 2006 |
Alveolar fluid reabsorption is increased in rats with compensated heart failure.
Topics: Adrenalectomy; Adrenergic beta-Antagonists; Amiloride; Animals; Cardiac Output; Disease Models, Anim | 2006 |
[Young woman with hyperthyroidism associated with severe tricuspid regurgitation].
Topics: Adrenergic beta-Antagonists; Adult; Echocardiography, Doppler; Female; Graves Disease; Heart Failure | 2008 |
Protective effect of the endothelin antagonist CPU0213 against isoprenaline-induced heart failure by suppressing abnormal expression of leptin, calcineurin and SERCA2a in rats.
Topics: Animals; Calcineurin; Cardiotonic Agents; Disease Models, Animal; Endothelin Receptor Antagonists; E | 2008 |
Left ventricular function and tissue hypoxia in irreversible hemorrhagic and endotoxin shock.
Topics: Animals; Blood Pressure; Cardiac Output; Dogs; Endotoxins; Heart; Heart Failure; Heart Rate; Heart V | 1967 |
Amelioration of angina pectoris in idiopathic hypertrophic subaortic stenosis with beta-adrenergic blockade.
Topics: Adult; Angina Pectoris; Blood Pressure; Cardiac Output; Cardiomyopathy, Hypertrophic; Exercise Test; | 1967 |
Effect of early propranolol treatment in an animal model of congestive cardiomyopathy. II. beta-adrenergic receptors and left ventricular function.
Topics: Animals; Cardiomyopathy, Dilated; Disease Models, Animal; Heart; Heart Failure; Heart Ventricles; Pr | 1984 |
Comparative hemodynamic effects of digoxin vs nitroprusside in conscious dogs with aortocaval fistula-induced chronic left ventricular volume overload and normal systolic performance.
Topics: Adrenergic beta-Antagonists; Animals; Aorta, Abdominal; Arteriovenous Fistula; Blood Volume; Chronic | 1982 |
[Therapeutic potential of beta-receptor blockers in acute anterior wall infarct].
Topics: Adrenergic beta-Antagonists; Aged; Heart Failure; Humans; Middle Aged; Myocardial Infarction; Propan | 1982 |
Low-dose beta blockade in the treatment of chronic cardiac failure.
Topics: Adrenergic beta-Antagonists; Adult; Heart Failure; Humans; Male; Metoprolol; Middle Aged; Propranolo | 1982 |
Clinical pharmacology of the beta-blocking drugs: implications for the postinfarction patient.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Bronchial Spasm; Fatigue; Heart Failure; Humans | 1983 |
Comparative effects of propranolol and nadolol on renal blood flow in normal rats and rats with congestive heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Heart Failure; Heart Rate; Male; Myocardial In | 1984 |
Beta-adrenergic blockage in congestive cardiomyopathy.
Topics: Aged; Cardiac Complexes, Premature; Cardiomyopathies; Female; Heart Failure; Humans; Propranolol; Pu | 1980 |
[Standard therapy of acute myocardial infarction.--II: Management of arrhythmias].
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atropine; Bradycardia; Cardiac Complexes, Premature; D | 1981 |
Plasma norepinephrine as an indicator of sympathetic neural activity in clinical cardiology.
Topics: Angina Pectoris; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Diazepam; Drug Interactions; He | 1981 |
Progression from hypertrophic obstructive cardiomyopathy to congestive cardiomyopathy in a child.
Topics: Adolescent; Cardiomegaly; Cardiomyopathy, Hypertrophic; Child; Female; Heart Failure; Humans; Long-T | 1982 |
Effect of early propranolol treatment in an animal model of congestive cardiomyopathy: I Mortality and Ca2+ transport in sarcoplasmic reticulum.
Topics: Animals; Biological Transport, Active; Calcium; Cardiomyopathy, Dilated; Disease Models, Animal; Hea | 1984 |
[Effect of various drugs on peripheral hemodynamics in left-ventricular insufficiency in patients with chronic ischemic heart disease].
Topics: Adult; Aged; Chronic Disease; Coronary Disease; Female; Heart Failure; Heart Ventricles; Hemodynamic | 1983 |
Therapeutic rounds at the Milton S. Hershey Medical Center: central nervous system toxicity caused by lidocaine.
Topics: Cognition Disorders; Confusion; Drug Interactions; Heart Failure; Humans; Lidocaine; Male; Middle Ag | 1983 |
The search for a digitalis substitute II milrinone (Win 47203). Its action on the heart-lung preparation of the dog.
Topics: Animals; Cardiotonic Agents; Dinitrophenols; Dogs; Heart; Heart Failure; Milrinone; Nifedipine; Papa | 1983 |
Sonographic evaluation of prenatal therapy for fetal supraventricular tachycardia and congestive heart failure. A case report.
Topics: Adult; Animals; Digoxin; Dogs; Female; Fetal Diseases; Heart Failure; Humans; Infant, Newborn; Pregn | 1983 |
[1st attempt at using the antioxidant dibunol in the acute stage of a myocardial infarct].
Topics: Acute Disease; Adult; Aged; Antioxidants; Butylated Hydroxytoluene; Drug Therapy, Combination; Femal | 1984 |
Nifedipine in hypertension and heart failure.
Topics: Adult; Aged; Blood Pressure; Delayed-Action Preparations; Drug Therapy, Combination; Female; Heart F | 1984 |
Suicide by ingestion of propranolol.
Topics: Heart Failure; Humans; Male; Middle Aged; Propranolol; Suicide | 1982 |
Noncardiac surgery and anesthesia in patients with heart disease.
Topics: Aged; Anesthesia; Anesthesia, Conduction; Anesthesia, Epidural; Anesthesia, Inhalation; Anesthesia, | 1982 |
Primary myocardial disease. Correlation with clinical findings, angiographic and biopsy diagnosis. Follow-up of 139 patients.
Topics: Alcohol Drinking; Arrhythmias, Cardiac; Biopsy; Cardiac Catheterization; Cardiomyopathies; Cardiomyo | 1980 |
[Treadmill exercise testing in patients with idiopathic cardiomyopathy (author's transl)].
Topics: Adult; Aged; Blood Pressure; Cardiomyopathies; Cardiomyopathy, Hypertrophic; Electrocardiography; He | 1980 |
[Standard therapy of acute myocardial infarction.--II. Management of hemodynamic complications. (author's transl)].
Topics: Analgesics; Atropine; Digoxin; Dobutamine; Dopamine; Drug Therapy, Combination; Heart Failure; Heart | 1981 |
[The end-systolic pressure-volume relationship in the assessment of left ventricular function (author's transl)].
Topics: Atropine; Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiac Volume; Coronary Disease; | 1981 |
Usefulness of the systolic time intervals in cardiovascular clinical cardiology.
Topics: Anti-Arrhythmia Agents; Coronary Disease; Digitalis Glycosides; Dose-Response Relationship, Drug; Fe | 1982 |
Hemodynamic and myocardial consequences of scorpion venom.
Topics: Animals; Arrhythmias, Cardiac; Atropine; Blood Gas Analysis; Blood Pressure; Cardiac Output; Dogs; F | 1980 |
Late recovery in peripartum cardiomyopathy.
Topics: Digoxin; Diuretics; Female; Heart Failure; Humans; Pregnancy; Propranolol; Puerperal Disorders; Time | 1980 |
Verapamil in the treatment of paroxysmal supraventricular tachycardia in infants and children.
Topics: Child; Child, Preschool; Digitalis Glycosides; Drug Interactions; Electrocardiography; Heart Failure | 1981 |
Positive and negative inotropic effects of DL-sotalol and D-sotalol in failing and nonfailing human myocardium under physiological experimental conditions.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Depression, Chemical; | 1995 |
Should beta-blocking agents be used in thyrotoxic heart disease?
Topics: Adult; Fatal Outcome; Heart Failure; Humans; Male; Middle Aged; Propranolol; Thyrotoxicosis | 1995 |
The effects of dobutamine, propranolol and nitroglycerin on an experimental canine model of congestive heart failure.
Topics: Analysis of Variance; Animals; Blood Pressure; Cardiac Output; Disease Models, Animal; Dobutamine; D | 1994 |
[Left heart failure in anesthesia in a child pretreated with propranolol--case report].
Topics: Adolescent; Anesthesia, General; Catheters, Indwelling; Drug Therapy, Combination; Female; Heart Fai | 1994 |
Effects of beta-blockade on neurohumoral responses and neurochemical markers in pacing-induced heart failure.
Topics: Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Bicarbonates; Biomarkers; Body Weight; Car | 1994 |
Successful treatment of life-threatening ventricular tachycardia with high-dose propranolol under extracorporeal life support and intraaortic balloon pumping.
Topics: Combined Modality Therapy; Extracorporeal Circulation; Heart Failure; Humans; Intra-Aortic Balloon P | 1993 |
1,4:3,6-Dianhydrohexitol nitrate derivatives. I. Synthesis and antianginal activity of alkylpiperazine derivatives.
Topics: Administration, Oral; Angina Pectoris; Animals; Anti-Arrhythmia Agents; Blood Pressure; Disease Mode | 1993 |
Effects of dopexamine on hemodynamics and oxygen consumption after beta blockade in lambs.
Topics: Animals; Animals, Newborn; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; | 1993 |
Cardiotonic activity of the water soluble forskolin derivative 8,13-epoxy-6 beta-(piperidinoacetoxy)- 1 alpha, 7 beta, 9 alpha-trihydroxy-labd- 14en-11-one.
Topics: Adenosine Diphosphate; Anesthesia; Animals; Cardiotonic Agents; Cats; Colforsin; Cricetinae; Dogs; E | 1993 |
beta-Adrenergic modulation of the inwardly rectifying potassium channel in isolated human ventricular myocytes. Alteration in channel response to beta-adrenergic stimulation in failing human hearts.
Topics: Adrenergic beta-Agonists; Adult; Alkaline Phosphatase; Analysis of Variance; Barium; Bucladesine; Ca | 1995 |
Acute effects of beta 1-selective and nonselective beta-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure.
Topics: Adrenergic beta-Antagonists; Epinephrine; Heart Conduction System; Heart Failure; Hemodynamics; Huma | 1996 |
Hemodynamic effects of different pacing ratios in chronic dynamic double cardiomyoplasty.
Topics: Acute Disease; Animals; Cardiac Pacing, Artificial; Cardiomyoplasty; Chronic Disease; Disease Models | 1996 |
Hemodynamic effects of cardiomyoplasty in an experimental model of acute heart failure and atrial fibrillation.
Topics: Acetylcholine; Animals; Atrial Fibrillation; Blood Pressure; Cardiac Output; Cardiomyoplasty; Diseas | 1996 |
Preferences of veterinarians for drugs to treat heart disease in dogs and cats.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Australia; Cardiotonic Agents; Cardiovascular | 1995 |
[Immunogenic hyperthyroidism with hyperdynamic heart failure and early cirrhotic transformation of the liver].
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Antithyroid Agents; Arrhythmias, Cardiac; Autoi | 1997 |
Beta-blocker therapy of severe congestive heart failure in infants with left to right shunts.
Topics: Adrenergic beta-Antagonists; Child, Preschool; Combined Modality Therapy; Female; Follow-Up Studies; | 1998 |
Physical activity, skeletal muscle beta-adrenoceptor changes and oxidative metabolism in experimental chronic heart failure.
Topics: Adrenergic beta-Antagonists; Analysis of Variance; Animals; Chronic Disease; Down-Regulation; Electr | 1998 |
Current insights and new treatment options in heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Coronary Disease; Heart Failure; Humans; | 1998 |
Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure.
Topics: Adrenergic beta-Antagonists; Aequorin; Animals; Calcium; Cardiotonic Agents; Coronary Circulation; E | 1999 |
Effects of propranolol on the QT dispersion in congestive heart failure.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Electrocardiography; Electrophysiology; Female; Heart Fail | 1999 |
Effects of prolonged propranolol treatment on left ventricular remodeling and oxidative stress after myocardial infarction in rats.
Topics: Animals; Anti-Arrhythmia Agents; Heart Failure; Male; Muscle Contraction; Myocardial Infarction; Oxi | 2000 |
Autonomic nervous system activity imbalance in cardiomyopathic hamster.
Topics: Animals; Autonomic Nervous System; Cardiomyopathies; Cricetinae; Heart; Heart Failure; Heart Rate; M | 2000 |
Selective or nonselective beta-adrenergic blockade in patients with congestive heart failure.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Heart Failure; Hemodynamics; Humans; M | 2000 |
Impaired elimination of propranolol due to right heart failure: drug clearance in the isolated liver and its relationship to intrinsic metabolic capacity.
Topics: Animals; Chromatography, High Pressure Liquid; Constriction; Cytochrome P-450 Enzyme System; Disease | 2000 |
Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Aging; Animals; Calcium-Binding Proteins; Cardiomyop | 2001 |
Arrhythmogenesis and contractile dysfunction in heart failure: Roles of sodium-calcium exchange, inward rectifier potassium current, and residual beta-adrenergic responsiveness.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Caffeine; Calc | 2001 |
Endogenous nitric oxide and soluble tumor necrosis factor receptor levels are enhanced in infants with congenital heart disease.
Topics: Adrenergic beta-Antagonists; Enzyme-Linked Immunosorbent Assay; Heart Defects, Congenital; Heart Fai | 2001 |
Propranolol prevents the development of heart failure by restoring FKBP12.6-mediated stabilization of ryanodine receptor.
Topics: Adrenergic beta-Antagonists; Animals; Calcium; Cardiac Pacing, Artificial; Diastole; Disease Models, | 2002 |
Strain-specific patterns of autonomic nervous system activity and heart failure susceptibility in mice.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Atropi | 2002 |
Effect of beta blockers on new congestive heart failure in older persons with healed myocardial infarcts.
Topics: Adrenergic beta-Antagonists; Aged; Carbazoles; Carvedilol; Heart Failure; Humans; Myocardial Infarct | 2002 |
Alternatives to practolol - the argument in more detail.
Topics: Adrenergic beta-Antagonists; Heart Failure; Humans; Oxprenolol; Practolol; Propranolol | 1975 |
Principles in selection of therapy.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Arrhythmias, Cardiac; Coronar | 1976 |
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Bronchi; Central Nervous System Diseases; Deafnes | 1979 |
[Non arrhythmogenic sudden death as complication of coronary heart disease].
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Coronary Artery Bypass; Coronary Disease; Death, | 1979 |
Complications of disopyramide therapy.
Topics: Bundle-Branch Block; Confusion; Disopyramide; Heart Failure; Humans; Male; Middle Aged; Propranolol; | 1979 |
Echocardiographic observations in hypertension.
Topics: Adolescent; Adult; Aged; Amyl Nitrite; Cardiomegaly; Cardiomyopathy, Hypertrophic; Echocardiography; | 1975 |
Clinical indicators of left main coronary artery disease in unstable angina.
Topics: Angina Pectoris; Angiography; Anticoagulants; Calcinosis; Cardiac Catheterization; Cardiomegaly; Col | 1979 |
Significance and treatment of nocturnal angina preceding myocardial infarction.
Topics: Acute Disease; Angina Pectoris; Cardiomegaly; Digitalis Glycosides; Electrocardiography; Female; Hea | 1977 |
Management of sudden coronary death.
Topics: Adult; Aged; Arrhythmias, Cardiac; Coronary Artery Bypass; Coronary Disease; Death, Sudden; Female; | 1977 |
New ideas in the management of heart failure in dogs.
Topics: Animals; Blood Pressure; Cardiac Output; Dog Diseases; Dogs; Heart Failure; Heart Rate; Nitroglyceri | 1977 |
Propranolol and coronary revascularization.
Topics: Dopamine; Drug Therapy, Combination; Heart Failure; Humans; Isoproterenol; Myocardial Contraction; M | 1979 |
When cardiac patients become surgical patients.
Topics: Aged; Anesthesia; Anti-Bacterial Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Bundle-Branch Bl | 1979 |
[Treatment of acute left-ventricular insufficiency complicated by tachyarrhythmia under conditions of cardiological emergency service].
Topics: Acute Disease; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Evaluation; Drug Ther | 1979 |
[Use of a betablockader in cardiac insufficiency].
Topics: Adult; Aged; Electrocardiography; Female; Heart Failure; Humans; Male; Propranolol; Tachycardia | 1979 |
Neonatal hyperthyroidism and heart failure. A differential approach.
Topics: Digitalis Glycosides; Echocardiography; Female; Graves Disease; Heart Failure; Heart Septal Defects, | 1977 |
[Congestive-type primary myocardiopathies: treatment with beta-blocking agents].
Topics: Adult; Cardiomyopathies; Heart Failure; Humans; Middle Aged; Pindolol; Propranolol | 1978 |
Mechanisms of beneficial effects of vasodilators and inotropic stimulation in the experimental failing ischemic heart.
Topics: Animals; Cardiac Output; Collateral Circulation; Coronary Circulation; Coronary Disease; Coronary Ve | 1978 |
Vasodilator and inotropic therapy of heart failure [panel discussion].
Topics: Animals; Cardiac Output; Coronary Circulation; Dobutamine; Dogs; Dose-Response Relationship, Drug; H | 1978 |
Studies on heart failure in old age (Part II). Hemodynamic effects of propranolol and isoproterenol in elderly patients with heart failure.
Topics: Aged; Blood Pressure; Blood Volume; Cardiac Output; Heart Failure; Heart Rate; Hemodynamics; Humans; | 1978 |
Long-term propranolol therapy for angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Asthma; Blood Pressure; Female; Heart Failure; Humans; Middle Aged; Ni | 1976 |
Haemodynamic effects of beta-adrenergic blockade in hyperthyroid patients with and without heart failure.
Topics: Heart Failure; Hemodynamics; Humans; Hyperthyroidism; Injections, Intravenous; Propranolol | 1977 |
[Sympathetic nervous activity and ischemic cardiopathy].
Topics: Aged; Angina Pectoris; Catecholamines; Coronary Disease; Heart Failure; Humans; Male; Middle Aged; M | 1977 |
Instantaneous force-velocity-length relations: experimental findings and clinical correlates.
Topics: Animals; Biomechanical Phenomena; Coronary Disease; Depression, Chemical; Dogs; Heart; Heart Failure | 1977 |
[Therapy of chronic ischemic heart disease and arterial hypertension by means of beta-receptor blockaders].
Topics: Adult; Coronary Disease; Heart Failure; Humans; Hypertension; Middle Aged; Practolol; Propranolol | 1976 |
Propranolol and management of arrhythmias.
Topics: Arrhythmias, Cardiac; Heart; Heart Block; Heart Failure; Hemodynamics; Humans; Propranolol | 1976 |
[Functional response of the hypertensive decompensated heart to the removal of adrenergic effects].
Topics: Adult; Aged; Guanethidine; Heart Failure; Humans; Hypertension; Male; Middle Aged; Propranolol; Rese | 1976 |
Geriatric cardiovascular problems.
Topics: Aged; Aging; Anesthesia; Arrhythmias, Cardiac; Blood Circulation; Cardiovascular Physiological Pheno | 1976 |
Intrapartum anesthetic management of the pregnant patient with heart disease.
Topics: Anesthesia, Epidural; Anesthesia, General; Anesthesia, Inhalation; Anesthesia, Local; Anesthesia, Ob | 1975 |
Minoxidil in severe hypertension: value when conventional drugs have failed.
Topics: Adult; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Edema; Female; | 1975 |
Cardiovascular effects of dopamine in the normal and failing heart of experimental animals.
Topics: Animals; Atropine; Blood Pressure; Cricetinae; Dogs; Dopamine; Dopamine Antagonists; Female; Guinea | 1975 |
Propranolol in the treatment of hypertension.
Topics: Arrhythmias, Cardiac; Brain; Bronchial Spasm; Depression, Chemical; Diuretics; Drug Synergism; Heart | 1976 |
Effects of beta-adrenergic blockade on papillary muscle function and the beta-adrenergic receptor system in noninfarcted myocardium in compensated ischemic left ventricular dysfunction.
Topics: Adenylyl Cyclases; Animals; Heart Failure; Male; Myocardial Contraction; Myocardial Infarction; Papi | 1992 |
Efficacy and safety of the novel Na+,K(+)-ATPase inhibitor 20R 14 beta-amino 3 beta-rhamnosyl 5 beta-pregnan 20 beta-ol in a dog model of heart failure.
Topics: Anesthesia; Animals; Cardiotonic Agents; Digoxin; Dogs; Female; Heart Failure; Hemodynamics; Male; M | 1992 |
[A study on the human beta-receptor regulation by dobutamine and propranolol].
Topics: Adult; Aged; Aged, 80 and over; Coronary Disease; Dobutamine; Female; Heart Failure; Humans; Male; M | 1992 |
[Bronchial hyperresponsiveness to acetylcholine during acute pulmonary congestion in guinea pigs].
Topics: Acetylcholine; Adrenergic beta-Antagonists; Airway Resistance; Animals; Bronchial Hyperreactivity; G | 1992 |
Autonomic nervous system dysfunction alters drug effects: implications for testing drugs for the treatment of heart failure.
Topics: Animals; Autonomic Nervous System; Cardiovascular Agents; Disease Models, Animal; Enalapril; Heart F | 1992 |
Ventricular contractility evaluated by mechanical perturbation of the myocardium--experimental and clinical approach adopting small amplitude vibration input.
Topics: Animals; Dobutamine; Dogs; Heart Failure; Humans; Myocardial Contraction; Propranolol; Ventricular F | 1992 |
Novel vascular effects of isoprenaline following pacing-induced heart failure in the dog.
Topics: Adrenergic Antagonists; Animals; Arteries; Dogs; Foot; Heart Failure; Hindlimb; In Vitro Techniques; | 1991 |
Efficacy of the glyceryl trinitrate transdermal therapeutic system in a dog model of heart failure.
Topics: Administration, Cutaneous; Animals; Cardiac Output; Dextrans; Disease Models, Animal; Dogs; Female; | 1991 |
Right ventricular dynamic cardiomyoplasty: an experimental model.
Topics: Animals; Back; Cardiac Output; Heart Failure; Models, Biological; Muscles; Propranolol; Sheep; Ventr | 1991 |
Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase activity.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Dose-Response Relationship, Drug; Heart Atria; Heart Fa | 1990 |
[Circulatory assist device in counterpulsation].
Topics: Animals; Counterpulsation; Dogs; Heart Failure; Heart-Assist Devices; Hemodynamics; Male; Plasma Sub | 1990 |
[The use of propranolol and verapamil in patients with ischemic heart disease].
Topics: Adult; Arrhythmias, Cardiac; Chronic Disease; Coronary Disease; Drug Evaluation; Female; Heart Failu | 1990 |
Attenuation of pressor responses to arginine vasopressin in right-sided congestive heart failure.
Topics: Animals; Aorta; Arginine Vasopressin; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Heart | 1990 |
[Correction of metabolic disorders of the myocardium in acute myocardial infarct as an important factor in preventing the development of circulatory insufficiency].
Topics: Animals; Aprotinin; Ascorbic Acid; Drug Therapy, Combination; Glutamates; Glutamic Acid; Heart Failu | 1985 |
Cardiovascular properties of MS-857, a new and potent cardiotonic agent, on normal and failing hearts.
Topics: Anesthesia; Animals; Cardiotonic Agents; Dogs; Female; Heart; Heart Failure; Isoquinolines; Lung; Ma | 1988 |
[The heart in patients with hypertension: effects of rilmenidine on experimental cardiac hypertrophy of hypertensive origin in rats].
Topics: Animals; Antihypertensive Agents; Cardiomegaly; Collagen; Heart; Heart Failure; Hypertension; Nephre | 1989 |
Drug- and disease-induced changes of human cardiac beta 1- and beta 2-adrenoceptors.
Topics: Adolescent; Adult; Cardiomyopathy, Dilated; Child; Child, Preschool; Coronary Disease; Heart Failure | 1989 |
Cardioprotective and antiarrhythmic effects of beta-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia.
Topics: Acetylglucosaminidase; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Bisoprolol; Coron | 1989 |
Catecholamine-responsive adenylate cyclase activity in human endomyocardial biopsies. Individual sensitivity to isoproterenol stimulation and propranolol inhibition.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Cardiomyopathy, Dil | 1985 |
[Clinical pharmacology of enalapril].
Topics: Angiotensin-Converting Enzyme Inhibitors; Chemical Phenomena; Chemistry; Drug Interactions; Enalapri | 1985 |
Sympathetic reflex control of skeletal muscle blood flow in patients with congestive heart failure: evidence for beta-adrenergic circulatory control.
Topics: Adult; Blood Pressure; Epinephrine; Forearm; Heart Failure; Heart Rate; Hemodynamics; Humans; Male; | 1986 |
The role of endogenous opioids in congestive heart failure: effects of nalmefene on systemic and regional hemodynamics in dogs.
Topics: Adrenocorticotropic Hormone; Animals; beta-Endorphin; Dogs; Endorphins; Heart Failure; Hemodynamics; | 1987 |
Short-term hemodynamic effects of vasopressin V1-receptor inhibition in chronic right-sided congestive heart failure.
Topics: Animals; Arginine Vasopressin; Cardiac Output; Chronic Disease; Dogs; Epinephrine; Heart Failure; He | 1988 |
Haemodynamic effects of insulin and beta receptor blockade during acute left ventricular failure in dogs.
Topics: Acute Disease; Animals; Blood Pressure; Cardiac Output; Coronary Circulation; Dogs; Drug Therapy, Co | 1986 |
Systemic and regional hemodynamic effects of isomazole in awake dogs with congestive heart failure.
Topics: Angiotensin II; Animals; Cardiac Output; Catecholamines; Dogs; Heart Failure; Heart Rate; Hemodynami | 1987 |
Cardiovascular pharmacology of 6-[4-(4'-pyridyl)aminophenyl]-4,5-dihydro-3(2H)-pyridazinone hydrochloride, a novel and potent cardiotonic agent with vasodilator properties.
Topics: Anesthesia; Animals; Cardiotonic Agents; Dogs; Female; Heart Failure; Hemodynamics; Hindlimb; Male; | 1987 |
Severe hypertension, propranolol, and acute pulmonary edema.
Topics: Aged; Aged, 80 and over; Drug Therapy, Combination; Heart Failure; Humans; Hydralazine; Hypertension | 1987 |
Pharmacology and pharmacokinetics of drugs used to treat cardiac disease in horses.
Topics: Administration, Oral; Animals; Arrhythmias, Cardiac; Cardiovascular Agents; Digoxin; Diuretics; Dobu | 1985 |
LV filling pressure during PEEP measured by nadir wedge pressure after airway disconnection.
Topics: Animals; Atrial Function; Blood Pressure; Cardiac Volume; Dogs; Heart; Heart Failure; Oleic Acid; Ol | 1985 |
The nature and prognosis of thyrotoxic heart disease.
Topics: Adult; Carbimazole; Female; Heart Diseases; Heart Failure; Hemodynamics; Humans; Hyperthyroidism; Io | 1985 |
Determinants of cardiac augmentation by elevations in intrathoracic pressure.
Topics: Acute Disease; Animals; Blood Pressure; Dogs; Heart; Heart Failure; Hemodynamics; Lung Volume Measur | 1985 |
Combination therapy with diltiazem and propranolol: precipitation of congestive heart failure.
Topics: Angina Pectoris; Benzazepines; Coronary Disease; Diltiazem; Dose-Response Relationship, Drug; Double | 1985 |
The beneficial effect of amrinone on acute drug-induced heart failure in the anaesthetised dog.
Topics: Aminopyridines; Amrinone; Animals; Blood Pressure; Cardiac Output; Cardiotonic Agents; Central Venou | 1985 |
[Treatment of cardiac rhythm disorders with beta-adrenergic blockaders, propranolol, benzodixin, visken, eraldin and trazikor].
Topics: Adolescent; Adult; Aged; Arrhythmia, Sinus; Arrhythmias, Cardiac; Arteriosclerosis; Atrial Fibrillat | 1971 |
Aneurysmectomy in treatment of ventricular and supraventricular tachyarrhythmias in patients with postinfarction and traumatic ventricular aneurysms.
Topics: Angiocardiography; Atrial Flutter; Cardiac Complexes, Premature; Digoxin; Electrocardiography; Heart | 1973 |
Idiopathic hypertrophic subaortic stenosis. Long-term surgical follow-up.
Topics: Adolescent; Adult; Aged; Angina Pectoris; Angiocardiography; Arrhythmias, Cardiac; Cardiac Catheteri | 1974 |
Phaeochromocytoma with catecholamine cardiomyopathy successfully treated surgically.
Topics: Acetanilides; Adrenergic beta-Antagonists; Amino Alcohols; Cardiomyopathies; Catecholamines; Central | 1972 |
Cardioselective beta blockade in hypertrophic cardiomyopathy.
Topics: Adolescent; Adrenergic beta-Antagonists; Blood Pressure; Cardiac Catheterization; Cardiac Output; Ca | 1972 |
Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 2. Clinical pharmacology.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmias, Cardiac; Drug Therapy, Combination; Heart Fail | 1973 |
Reversal of verapamil-, dichloroisoproterenol-, and propranolol-induced cardiac failure by histamine.
Topics: Animals; Blood Pressure; Cardiac Output; Depression, Chemical; Female; Guinea Pigs; Heart Atria; Hea | 1974 |
The natural (and unnatural) history of hypertrophic obstructive cardiomyopathy.
Topics: Adolescent; Adult; Age Factors; Aged; Blood Pressure; Cardiomyopathies; Child; Child, Preschool; Dea | 1974 |
Hypotension after oral propranolol.
Topics: Heart Failure; Humans; Hypotension; Male; Middle Aged; Propranolol | 1968 |
Glucagon therapy in heart-failure.
Topics: Animals; Cyclic AMP; Dogs; Glucagon; Heart Failure; Humans; Propranolol | 1969 |
Glucagon therapy in heart-failure.
Topics: Glucagon; Heart Failure; Humans; Propranolol | 1969 |
Congestive and hypertrophic cardiomyopathies. A decade of study.
Topics: Blood Pressure; Cardiomegaly; Coronary Disease; Death, Sudden; Dilatation; Female; Heart Diseases; H | 1970 |
[Valsalva's maneuver as an over-all test of myocardial function].
Topics: Adult; Aged; Anesthesia, General; Aortic Valve Stenosis; Atropine; Blood Pressure; Cardiac Catheteri | 1972 |
Sympathetic and parasympathetic components of reflex tachycardia induced by hypotension in conscious dogs with and without heart failure.
Topics: Animals; Atropine; Blood Pressure; Depression, Chemical; Dogs; Heart Failure; Heart Rate; Hypotensio | 1974 |
[Combined administration of obzidan and sustak in the treatment of patients with chronic coronary insufficiency].
Topics: Adult; Aged; Chronic Disease; Drug Therapy, Combination; Female; Heart; Heart Failure; Humans; Male; | 1974 |
Unwanted effects of propranolol.
Topics: Blood Cell Count; Blood Urea Nitrogen; Bradycardia; Drug Eruptions; Enzymes; Heart Failure; Humans; | 1966 |
Cardiac adrenergic activity in experimental heart failure assessed with beta receptor blockade.
Topics: Animals; Blood Pressure; Carbon Dioxide; Cardiac Output; Cardiomegaly; Cattle; Epinephrine; Heart; H | 1969 |
Rate corrected systolic time intervals and Valsalva manoeuvre.
Topics: Adult; Atropine; Cardiomegaly; Cardiomyopathies; Coronary Disease; Electrocardiography; Female; Hear | 1973 |
Effects of oxyfedrine and ouabain on the heart-lung preparation of the dog.
Topics: Amino Alcohols; Animals; Arrhythmias, Cardiac; Cardiac Output; Disease Models, Animal; Dogs; Female; | 1973 |
The "natural" history of severe angina pectoris with intensive medical therapy alone: a five year prospective study of 133 patients.
Topics: Adult; Aged; Aging; Angina Pectoris; Atrial Fibrillation; Cardiomegaly; Cerebrovascular Disorders; D | 1974 |
[The heart in hyperthyroidism (83 cases). II. Treatment of cardiothyrotoxicosis].
Topics: Adult; Age Factors; Anticoagulants; Arrhythmias, Cardiac; Coronary Disease; Electric Countershock; E | 1969 |
Mechanisms regulating renin release in dogs with thoracic caval constriction.
Topics: Angiotensin II; Animals; Ascites; Blood Pressure; Constriction; Creatinine; Disease Models, Animal; | 1972 |
[Propranolol and cardiac insufficiency].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Electrocardiography; Female; Heart Failure; Humans; Male; | 1969 |
Autonomic control of insulin secretion and the treatment of heart failure.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Adult; Atropine; Autonomic Nervous System; F | 1970 |
Use of propranolol in thyrotoxicosis.
Topics: Adrenergic beta-Antagonists; Cardiac Output; Heart Failure; Humans; Hyperthyroidism; Propranolol | 1971 |
Trial of practolol (Eraldin) in treatment of supraventricular cardiac arrhythmias in the elderly.
Topics: Acetanilides; Administration, Oral; Adrenergic beta-Antagonists; Aged; Amino Alcohols; Anxiety; Arrh | 1970 |
Intrinsic sympathomimetic activity in relation to the precipitation of heart failure by beta-adrenoceptive blockade.
Topics: Adrenergic beta-Antagonists; Animals; Cardiac Output; Drug Antagonism; Extracorporeal Circulation; F | 1971 |
[3d heart sound].
Topics: Adult; Animals; Arrhythmias, Cardiac; Cardiac Catheterization; Cardiomyopathies; Dogs; Ductus Arteri | 1971 |
[Therapy of tachyarrhythmia by implantation of pacemakers].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Allyl Compounds; Amino Alcohols; Arrhythmias, Cardiac; Dig | 1972 |
[Comparison of the hemodynamic effects in man of 2 beta-blockaders: propranolol and practolol].
Topics: Acetanilides; Adrenergic beta-Antagonists; Amino Alcohols; Blood Pressure; Cardiac Output; Coronary | 1972 |
Paroxysmal supraventricular tachycardia in infancy and childhood.
Topics: Atrial Fibrillation; Atrial Flutter; Atrioventricular Node; Child; Congenital Abnormalities; Deliver | 1974 |
Bradycardia-tachycardia syndrome: results in twenty-eight patients treated by combined pharmacologic therapy and pacemaker implantation.
Topics: Aged; Atropa belladonna; Atropine; Autopsy; Bradycardia; Digitalis Glycosides; Ephedrine; Female; He | 1974 |
Dissection of the thoracic aorta. Medical or surgical therapy?
Topics: Adult; Aged; Aorta, Thoracic; Aortic Aneurysm; Aortic Valve Insufficiency; Autonomic Agents; Blood P | 1974 |
Mechanism and management of chaotic atrial mechanism.
Topics: Acute Disease; Chronic Disease; Coronary Disease; Digitalis Glycosides; Drug Therapy, Combination; E | 1974 |
Left ventricular bypass for ventricular failure. Technical and hemodynamic considerations.
Topics: Animals; Aorta, Thoracic; Assisted Circulation; Cardiac Output; Constriction; Coronary Vessels; Dogs | 1973 |
Comparative measurements of left-ventricular performance produced by rapid changes in blood volume in dogs.
Topics: Animals; Aorta; Assisted Circulation; Blood Flow Velocity; Blood Pressure; Blood Transfusion; Blood | 1972 |
[Serious rhythm disorders in the Wolff-Parkinson-White syndrome].
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Child, Preschool; Electric Countershock; Electrocardiograph | 1973 |
Dosage regimens of antiarrhythmics. II. Applications.
Topics: Anti-Arrhythmia Agents; Heart Failure; Humans; Injections, Intravenous; Kidney Diseases; Lidocaine; | 1973 |
Experimental and early clinical evaluation of heart tracking (radarkymography) as a noninvasive method for measuring myocardial contractility.
Topics: Analog-Digital Conversion; Animals; Aorta; Blood Flow Velocity; Blood Pressure; Cardiac Output; Card | 1973 |
Coexistence of passive and active junctional rhythms with rates up to 300 per minute in a child with atrial parasystole.
Topics: Age Factors; Arrhythmia, Sinus; Cardiac Catheterization; Child; Digoxin; Diuretics; Electrocardiogra | 1973 |
The examination of intrinsic heart rate in the differential diagnosis of hyperthyroidism and vegetative dystonia, in hypertension and in congestive heart failure due to coronary sclerosis.
Topics: Adolescent; Adult; Age Factors; Aged; Atropine; Child; Coronary Disease; Diagnosis, Differential; Dy | 1973 |
Congestive heart failure. A new iatrogenic epidemic, propranolol (Inderal) induced.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Female; Heart Failure; Humans; Male; Middle Aged | 1974 |
[Evaluation of some methods of treating cardiac arrhythmias].
Topics: Adams-Stokes Syndrome; Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillatio | 1974 |
Medical and surgical treatment of the cardiomyopathies.
Topics: Alcohol Drinking; Anticoagulants; Cardiomyopathies; Cardiomyopathy, Hypertrophic; Diet, Sodium-Restr | 1974 |
Species variability in hemodynamic response to paired-pulse stimulation.
Topics: Animals; Cattle; Dogs; Electric Stimulation; Electrocardiography; Goats; Haplorhini; Heart; Heart Fa | 1969 |
[Conservative therapy of angina pectoris].
Topics: Acute Disease; Amyl Nitrite; Angina Pectoris; Anticoagulants; Coronary Disease; Digitalis Glycosides | 1970 |
The effects of reserpine and propranolol on the therapeutic and toxic effects of peruvoside in the heart-lung preparation and intact dogs.
Topics: Animals; Arrhythmias, Cardiac; Cardanolides; Cardiac Glycosides; Dogs; Drug Antagonism; Extracorpore | 1972 |
New drugs for old. I. Hypertension and cardiac failure.
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Diuretics; Heart Failure; Hypertension; Hypoglycemic Agents | 1972 |
Treatment of refractory supraventricular arrhythmias with induced permanent atrial fibrillation.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atropine; Bradycardia; Cardiac Catheterization; Digitalis | 1971 |
Attempted surgical division of the preexcitation pathway in the Wolff-Parkinson-White syndrome.
Topics: Arrhythmias, Cardiac; Digoxin; Electrocardiography; Heart Conduction System; Heart Failure; Humans; | 1971 |
Medical vs surgical treatment of acute dissecting aneurysms.
Topics: Acute Disease; Acute Kidney Injury; Adult; Aged; Aortic Aneurysm; Aortic Rupture; Aortography; Blood | 1971 |
[Changes in pulse, blood pressure, heart size and ECG following administration of practolol (ICI 50172)].
Topics: Acetanilides; Adult; Arrhythmias, Cardiac; Blood Pressure; Electrocardiography; Exercise Test; Heart | 1971 |
Experimental graded "pump failure" of the left ventricle.
Topics: Animals; Aorta, Thoracic; Blood Flow Velocity; Blood Pressure; Carbon Dioxide; Cardiac Output; Cardi | 1971 |
Dissociation of factors influencing myocardial degeneration and generalized cardiocirculatory failure.
Topics: Animals; Aspartic Acid; Cricetinae; Diet; Digitoxin; Disease Models, Animal; Edema; Epinephrine; Fem | 1969 |
[Effect of combined cardiac glycoside and propranolol administration on the dynamics of total left ventricular contraction].
Topics: Cardiac Glycosides; Chronic Disease; Electrocardiography; Heart Failure; Humans; Propranolol | 1969 |
[Prolonged supraventricular ectopic tachycardia in the child. (16 cases)].
Topics: Arrhythmia, Sinus; Child; Child, Preschool; Digoxin; Electrocardiography; Electroconvulsive Therapy; | 1969 |
Natural history of ventricular septal defect with right-sided aortic arch.
Topics: Angiocardiography; Aorta, Thoracic; Child; Child, Preschool; Cineangiography; Congenital Abnormaliti | 1970 |
Angina pectoris--II.
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Cholesterol; Cholestyramine Resin; Clofibrate; D | 1971 |
[Clinical effect and hemodynamic changes during the use of Inderal].
Topics: Adult; Aged; Angina Pectoris; Arrhythmias, Cardiac; Blood Flow Velocity; Cardiac Output; Cardiovascu | 1967 |
[Acute cardiac decompensation following propranolol therapy].
Topics: Acute Disease; Animals; Catecholamines; Electrocardiography; Guinea Pigs; Heart Failure; Humans; Mal | 1967 |
Cardio-circulatory effects of beta-adrenergic blockade in organic heart disease. Comparison between propranolol and CIBA 39,089-Ba.
Topics: Adult; Blood Pressure; Cardiac Catheterization; Cardiac Output; Chemical Phenomena; Chemistry; Femal | 1968 |
Propranolol (inderal).
Topics: Heart Failure; Humans; Propranolol | 1968 |
Cardiac failure with propranolol.
Topics: Aortic Valve Insufficiency; Heart Failure; Humans; Mitral Valve Insufficiency; Propranolol; Rheumati | 1968 |
Cardiac failure in patients with valvar heart disease after use of propranolol to control atrial fibrillation.
Topics: Adult; Aortic Valve; Atrial Fibrillation; Digoxin; Female; Heart Failure; Heart Rate; Heart Valve Di | 1968 |
Cardiac work and contractility.
Topics: Animals; Biomechanical Phenomena; Calcium; Catecholamines; Digitalis Glycosides; Heart; Heart Failur | 1968 |
Glucagon. Its enhancement of cardiac performance in the cat and dog and persistence of its inotropic action despite beta-receptor blockade with propranolol.
Topics: Animals; Blood Pressure; Catecholamines; Cats; Dogs; Glucagon; Heart; Heart Atria; Heart Failure; He | 1968 |
Hospital mortality in acute myocardial infarction.
Topics: Acute Disease; Aged; Angina Pectoris; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden; E | 1968 |
Hemodynamic effect of a combined therapy with propranolol and digoxin.
Topics: Digitalis Glycosides; Digoxin; Heart; Heart Failure; Hemodynamics; Humans; Male; Myocardium; Oxygen | 1968 |
Successful surgical interruption of the bundle of Kent in a patient with Wolff-Parkinson-White syndrome.
Topics: Adult; Digitalis Glycosides; Electric Countershock; Electrocardiography; Heart Conduction System; He | 1968 |
Is the ejection fraction an index of myocardial contractility?
Topics: Animals; Blood Transfusion; Blood Volume; Cardiac Catheterization; Cardiac Output; Dogs; Heart Failu | 1968 |
[Unfavourable cardiovascular effects of propranolol].
Topics: Adolescent; Adult; Arrhythmias, Cardiac; Atrial Fibrillation; Electrocardiography; Female; Heart Blo | 1968 |
The tissue catecholamine concentration of the rabbit in experimental cardiac failure.
Topics: Adrenal Glands; Animals; Aorta; Brain Stem; Catecholamines; Epinephrine; Female; Guanidines; Heart F | 1968 |
The hemodynamic effects of paired pacing of the myocardium in reversible acute heart failure in the canine.
Topics: Animals; Atropine; Blood Pressure; Cardiac Catheterization; Cardiac Output; Dogs; Electrocardiograph | 1969 |
[After-contractions as a cause of late diastolic "tonus increase" of the heart. Studies of diastolic extensibility of the isolated frog heart under propranolol, hexobarbital and k-strophanthin].
Topics: Animals; Cardiac Output; Cardiac Volume; Heart; Heart Failure; Heart Function Tests; Hexobarbital; M | 1969 |
The coronary attack: concepts on its etiology and hemodynamic management.
Topics: Aged; Arrhythmias, Cardiac; Aspartate Aminotransferases; Biophysical Phenomena; Biophysics; Blood Fl | 1969 |